1
|
Cetinkaya H, Gursu M, Yazici H, Cebeci E, Eren N, Altiparmak MR, Akcay OF, Sahin G, Dheir H, Basturk T, Atilgan KG, Aydemir N, Turgutalp K, Yilmaz M, Sirali SK, Tatar E, Boz EG, Mirioglu S, Kazan S, Aydin E, Aydin Z, Turkmen K, Kutlay S, Karagoz F, Ogutmen MB, Ozturk S, Ozkan O, Yildiz N, Dincer T, Yasar E, Gok M, Turkmen A, Dede F, Derici U. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy? J Nephrol 2023:10.1007/s40620-023-01770-1. [PMID: 37947938 DOI: 10.1007/s40620-023-01770-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Accepted: 08/18/2023] [Indexed: 11/12/2023]
Abstract
BACKGROUND Immunoglobulin A nephropathy (IgAN) is a common primary glomerulonephropathy. There is evidence that mesangial C3 deposition plays a role in the development of the disease. The aim of this study was to examine the effect of C3 deposition on the prognosis of IgAN patients. METHOD The study included 1135 patients with biopsy-confirmed IgAN from the database of the Turkish Nephrology Association Glomerular Diseases Working Group (TSN-GOLD). Patients were excluded from the study if they were aged < 18 or > 75 years or if C3 staining had not been performed in the immunofluorescent analysis. C3 deposition was defined as an immunofluorescence intensity of C3 ≥ 2 + within the mesangium. The primary endpoints were the development of end-stage renal disease, a 30% decrease in glomerular filtration rate compared to the basal value or an elevation in proteinuria to a nephrotic level (3.5 gr/day). RESULTS Mesangial C3 deposition was observed in 603 (53.1%) patients. No statistically significant difference was found at baseline between the groups with and without mesangial C3 deposition, as for age, sex, BMI, proteinuria level, or the presence of hypertension. In the follow-up period with a mean duration of 78 months, no significant difference was found between the two groups regarding the primary endpoints (p = 0.43). A significant correlation between C3 deposition and segmental glomerulosclerosis (S1) according to the Oxford MEST-C classification was found (p = 0.001). CONCLUSION Although a correlation was observed between mesangial C3 deposition and the S1 MEST-C classification, mesangial C3 deposition was not a prognostic factor in IgAN.
Collapse
Affiliation(s)
- Hakki Cetinkaya
- Department of Nephrology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
| | - Meltem Gursu
- Medical Faculty, Nephrology, Bezmialem Vakif University, Istanbul, Turkey
| | - Halil Yazici
- Istanbul Medical Faculty, Nephrology, Istanbul University, Istanbul, Turkey
| | - Egemen Cebeci
- Department of Nephrology, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Necmi Eren
- Medical Faculty, Nephrology, Kocaeli University, Izmit, Kocaeli, Turkey
| | | | | | - Gulizar Sahin
- Department of Nephrology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Hamad Dheir
- Medical Faculty, Nephrology, Sakarya University, Adapazari, Sakarya, Turkey
| | - Taner Basturk
- Department of Nephrology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Kadir Gokhan Atilgan
- Department of Nephrology, Diskapi Training and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - Nihal Aydemir
- Department of Nephrology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey
| | - Kenan Turgutalp
- Division of Nephrology, Department of Internal Medicine, Mersin University School of Medicine, Mersin, Turkey
| | - Murvet Yilmaz
- Department of Nephrology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Semahat Karahisar Sirali
- Department of Nephrology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - Erhan Tatar
- Department of Nephrology, Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey
| | - Elif Gullulu Boz
- Division of Nephrology, Department of Internal Medicine, Uludag University School of Medicine, Bursa, Turkey
| | - Safak Mirioglu
- Medical Faculty, Nephrology, Bezmialem Vakif University, Istanbul, Turkey
| | - Sinan Kazan
- Department of Nephrology, Afyonkarahisar School of Medicine, University of Health Sciences, Afyonkarahisar, Turkey
| | - Emre Aydin
- Medical Faculty, Nephrology, Dicle University, Diyarbakir, Turkey
| | - Zeki Aydin
- Department of Nephrology, Darica Farabi Training and Research Hospital, University of Health Sciences, Darica, Kocaeli, Turkey
| | - Kultigin Turkmen
- Meram Medical Faculty, Nephrology, Necmettin Erbakan University, Konya, Turkey
| | - Sim Kutlay
- Medical Faculty, Nephrology, Ankara University, Ankara, Turkey
| | - Ferdi Karagoz
- Medical Faculty, Nephrology, Trakya University, Edirne, Turkey
| | - Melike Betul Ogutmen
- Department of Nephrology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Savas Ozturk
- Istanbul Medical Faculty, Nephrology, Istanbul University, Istanbul, Turkey
| | - Oktay Ozkan
- Department of Nephrology, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Nuriye Yildiz
- Medical Faculty, Nephrology, Kocaeli University, Izmit, Kocaeli, Turkey
| | - Tamer Dincer
- Cerrahpasa Medical Faculty, Nephrology, Istanbul University, Istanbul, Turkey
| | - Emre Yasar
- Medical Faculty, Nephrology, Gazi University, Ankara, Turkey
| | - Mahmut Gok
- Department of Nephrology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Aydın Turkmen
- Istanbul Medical Faculty, Nephrology, Istanbul University, Istanbul, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey
| | - Ulver Derici
- Medical Faculty, Nephrology, Gazi University, Ankara, Turkey
| |
Collapse
|
2
|
Yenigun EC, Turgut D, Cevher SK, Yucel C, Aypak C, Dede F. Blood pressure response to exercise in unaffected relatives of autosomal dominant polycystic kidney disease patients: an observational study. Int Urol Nephrol 2023; 55:2313-2319. [PMID: 36872421 DOI: 10.1007/s11255-023-03535-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2022] [Accepted: 02/21/2023] [Indexed: 03/07/2023]
Abstract
INTRODUCTION Hypertension is an early finding of autosomal dominant polycystic kidney disease (ADPKD) and is related to different mechanisms. Cyst expansion-related renin secretion or early endothelial dysfunctions are some of these hypotheses. In addition, the underlying genetic factor is thought to play a role in the inheritance of hypertension. The differential course of hypertension in ADPKD preoccupies that relatives of ADPKD patients may also be at risk for this underlying mechanisms with a genetically determined abnormal endothelial-vascular state. In this study, we aimed to evaluate blood pressure response to exercise as an initial vascular problem in unaffected and normotensive relatives of hypertensive ADPKD patients. METHODS This is an observational study including unaffected and normotensive relatives (siblings and children) of ADPKD patients (relative group) and healthy controls (control group) who performed an exercise stress test. A 6-lead electrocardiogram was recorded and blood pressure was measured automatically with a cuff worn on the right arm, immediately before the test and every 3 min during the exercise and the recovery phase. Participants continued the test until their age-specific target heart rate was reached or symptoms occurred that required discontinuation of the test. The highest blood pressure and pulse values during exercise were noted. In addition, as a marker for endothelial function, nitric oxide (NO) and asymmetric dimethylarginine (ADMA) levels were measured at baseline and post-exercise. RESULTS There were 24 participants in the relative group (16 female, mean age 38.45 years) and 30 participants in the control group (15 female, mean age 37.96 years). Two groups were similar in terms of age, gender, body mass index (BMI), smoking status, resting systolic blood pressure (SBP)/diastolic blood pressure (DBP) and biochemical parameters. Mean SBP and DBP were similar in both groups during 1st, 3rd and 9th minutes of exercise (1st minute: 136.25 ± 19.71 mmHg vs 140.36 ± 30.79 mmHg for SBP, p = 0.607, 84.05 ± 14.75 mmHg vs 82.60 ± 21.60 mmHg for DBP, p = 0.799; 3rd minute: 150.75 ± 30.39 mmHg vs 148.54 ± 27.30 mmHg for SBP, p = 0.801, 98.95 ± 26.92 mmHg vs 85.92 ± 17.93 mmHg for DBP, p = 0.062; 9th minute: 156.35 ± 30.84 mmHg vs 166.43 ± 31.90 mmHg for SBP, p = 0.300, 96.25 ± 21.99 mmHg vs 101.78 ± 33.11 mmHg for DBP, p = 0.529 for control and relatives, respectively). During the recovery phase, SBP decreased in both groups in 6th minute (119.85 ± 14.06 mmHg vs 122.86 ± 16.76 mmHg, p = 0.538 for control and relatives respectively); however, in the relatives of ADPKD patients DBP remained high at the end of the 6th minute (78.95 ± 11.29 mmHg vs 86.67 ± 9.81 mmHg p = 0.025 for control and relatives, respectively). Baseline and post-exercise NO and ADMA levels were similar in both groups (Baseline p = 0.214 and p = 0.818, post-exercise p = 0.652 and p = 0.918 for NO and ADMA, respectively). CONCLUSION Abnormal blood pressure response to exercise was observed in unaffected normotensive relatives of ADPKD. Although its clinical significance needs to be demonstrated by additional research, it is an important finding that unaffected relatives of ADPKD may be at risk for an altered arterial vascular network. Furthermore, these data are the first to demonstrate that relatives of ADPKD patients may also be under risk with a genetically determined abnormal vascular state.
Collapse
Affiliation(s)
| | | | | | - Cigdem Yucel
- Gülhane EAH, Ankara Gulhane Egitim ve Arastirma Hastanesi, Ankara, Turkey
| | - Cenk Aypak
- Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Saglik Bilimleri Universitesi Diskapi Yildirim Beyazit Egitim ve Arastirma Hastanesi, Ankara, Turkey
| | | |
Collapse
|
3
|
Göre B, Yenigün EC, Cevher ŞK, Çankaya E, Aydın N, Dede F. IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report. Future Virol 2022. [PMID: 35783673 PMCID: PMC9246087 DOI: 10.2217/fvl-2021-0314] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Accepted: 06/15/2022] [Indexed: 11/25/2022]
Abstract
A 56-year-old male admitted to the hospital for generalized weakness and fever. He was treated in hospital for 10 days due to COVID-19. He did not receive any immunosuppressive therapy during admission. One day after his discharge he experienced back pain and received analgesic therapy for 10 days. About one month later he experienced severe back pain and gross hematuria. He was admitted to hospital with acute kidney injury and new-onset lower extremity muscle weakness. His renal biopsy revealed IgA nephropathy and thoracic/cervical/lumbar-spine imaging showed an epidural abscess. This is a unique case report of a patient developing an epidural abscess and acute kidney injury together as a serious complication of COVID-19 infection.
Collapse
Affiliation(s)
- Burak Göre
- Department of Internal Medicine, Ankara City Hospital, Ankara, 06800, Turkey
| | | | | | - Emre Çankaya
- Department of Nephrology, Ankara City Hospital, Ankara, 06800, Turkey
| | - Numan Aydın
- Department of Internal Medicine, Ankara City Hospital, Ankara, 06800, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara City Hospital, Ankara, 06800, Turkey
| |
Collapse
|
4
|
Gül CB, Küçük M, Öztürk S, Demir E, Eren N, Şumnu A, Seyahi N, Güllülü M, Dede F, Derici Ü, Koç Y, Şahin G, Oymak O, Sahin GM, Tatar E, Dursun B, Dheir H, Apaydın S, Süleymanlar G, Ulu S, Altınören O, Kutlay S, Meşe M, Şahin İ, Üstündağ S, Türkmen K, Yılmaz ME, Kazancıoğlu RT, Uzun Ö, Candan F, Aydın Z, Oygar D, Aktaş N, Erdem Y, Paydaş S, Taymez D, Can B, Kıykım A, Koç L, Sezer S, Duranay M, Bardak S, Altıntepe L, Kaya B, Azak A, Ecder SA, Çavdar C, Selçuk NY. Trends of primary glomerular disease in Turkey: TSN-GOLD registry report. Int Urol Nephrol 2022; 54:2285-2294. [PMID: 35107695 DOI: 10.1007/s11255-022-03123-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 01/11/2022] [Indexed: 11/28/2022]
Abstract
BACKGROUND Although several renal biopsy registry reports have been published worldwide, there are no data on primary glomerular disease trends in Turkey. METHODS Three thousand eight-hundred fifty-eight native kidney biopsy records were assessed in the Turkish Society of Nephrology Primary Glomerulopathy Working Group (TSN-GOLD) Registry. Secondary disease and transplant biopsies were not recorded in the registry. These records were divided into four periods, before 2009, 2009 to 2013, 2013-2017, and 2017-current. RESULTS A total of 3858 patients (43.6% female, 6.8% elderly) were examined. Nephrotic syndrome was the most common biopsy indication in all periods (58.6%, 53%, 44.1%, 51.6%, respectively). In the whole cohort, IgA nephropathy (IgAN) (25.7%) was the most common PGN with male predominance (62.7%), and IgAN frequency steadily increased through the periods (× 2 = 198, p < 0.001). MGN was the most common nephropathy in the elderly (> 65 years), and there was no trend in this age group. An increasing trend was seen in the frequency of overweight patients (× 2 = 37, p < 0.0001). Although the biopsy rate performed with interventional radiology gradually increased, the mean glomeruli count in the samples did not change over the periods. CONCLUSIONS In Turkey, IgAN is the most common primary glomerulonephritis, and the frequency of this is increasing.
Collapse
Affiliation(s)
- Cuma Bülent Gül
- Department of Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
| | - Mehmet Küçük
- Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey
| | - Savaş Öztürk
- Nephrology, Haseki Training and Resarch Hospital, Istanbul, Turkey
| | - Erol Demir
- Nephrology, Istanbul University Medical School, Istanbul, Turkey
| | - Necmi Eren
- Nephrology, Kocaeli University School of Medicine, Kocaeli, Turkey
| | - Abdullah Şumnu
- Faculty of Medicine, Nephrology, Medipol University Hospital, Istanbul, Turkey
| | - Nurhan Seyahi
- Nephrology, Cerrahpasa University Medical School, Istanbul, Turkey
| | - Mustafa Güllülü
- Nephrology, Uludag University Medical Faculty Hospital, Bursa, Turkey
| | - Fatih Dede
- Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ülver Derici
- Nephrology, Gazi University Medical Faculty, Ankara, Turkey
| | - Yener Koç
- Nephrology, Sisli Hamidiye Training and Research Hospital, Istanbul, Turkey
| | - Garip Şahin
- Nephrology, Osmangazi University, Odunpazarı, Eskisehir, Turkey
| | - Oktay Oymak
- Nephrology, Erciyes University, Kayseri, Turkey
| | - Gülizar Manga Sahin
- Nephrology, Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey
| | - Erhan Tatar
- Nephrology, Bozyaka Training and Research Hospital, Izmir, Turkey
| | - Belda Dursun
- Nephrology, Pamukkale University, Denizli, Turkey
| | - Hamad Dheir
- Nephrology, Sakarya Training and Research Hospital, Sakarya, Turkey
| | - Süheyla Apaydın
- Istanbul Sadi Konuk Training and Research Hospital, Istanbul, Turkey
| | | | - Sena Ulu
- Nephrology, Afyon Kocatepe University Medical School, Afyonkarahisar, Turkey
| | - Orçun Altınören
- Nephrology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| | - Sim Kutlay
- Faculty of Medicine, Nephrology, Ankara University, Ankara, Turkey
| | - Meral Meşe
- Nephrology, Istanbul Dr Lufti Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - İdris Şahin
- Nephrology, Inonu University Medical School, Malatya, Turkey
| | - Sedat Üstündağ
- Nephrology, Trakya University Medical School, Edirne, Turkey
| | - Kültigin Türkmen
- Nephrology, Necmettin Erbakan University Meram Medical School, Konya, Turkey
| | | | | | - Özcan Uzun
- Nephrology, Dokuz Eylul University Medical School, Izmir, Turkey
| | - Ferhan Candan
- Nephrology, Cumhuriyet University Medical School, Sivas, Turkey
| | - Zeki Aydın
- Nephrology, Darıca Farabi Training and Research Hospital, Kocaeli, Turkey
| | - Deren Oygar
- Nephrology, Lefkosa Burhan Nalbantoglu Hospital, Lefkosa, Turkish Republic of Northern Cyprus
| | - Nimet Aktaş
- Department of Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
| | - Yunus Erdem
- Nephrology, Hacettepe University Medical School, Ankara, Turkey
| | - Saime Paydaş
- Nephrology, Cukurova University Medical School, Adana, Turkey
| | - Dilek Taymez
- Nephrology, Kocaeli State Hospital, Kocaeli, Turkey
| | - Başak Can
- Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey
| | - Ahmet Kıykım
- Nephrology, Mersin University Medical School, Mersin, Turkey
| | - Leyla Koç
- Nephrology, Taksim Training and Research Hospital, Istanbul, Turkey
| | - Siren Sezer
- Nephrology, Baskent University Medical School, Ankara, Turkey
| | - Murat Duranay
- Nephrology, Ankara Atatürk Training and Research Hospital, Ankara, Turkey
| | - Simge Bardak
- Nephrology, Batman State Hospital, Batman, Turkey
| | | | - Burcu Kaya
- Nephrology, Marmara University Medical School, Istanbul, Turkey
| | - Alper Azak
- Nephrology, Balıkesir Training and Research Hospital, Balikesir, Turkey
| | - Sebahat Alışır Ecder
- Nephrology, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Caner Çavdar
- Nephrology, Dokuz Eylul University Medical School, Izmir, Turkey
| | - Nedim Yılmaz Selçuk
- Nephrology, Necmettin Erbakan University Meram Medical School, Konya, Turkey
| |
Collapse
|
5
|
Cevher ŞK, Yenigün EC, Çankaya E, Aktürk S, Levent M, Aypak A, Dede F. Should We Weigh More on Home Dialysis Methods During Pandemic Periods: One Center Experience. Turk J Nephrol 2022. [DOI: 10.5152/turkjnephrol.2022.21073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
6
|
Comoglu M, Dede F, Yenigun EC, Topcuoglu C, Inan O, Sahiner ES, Ates I. Effects of Medium Cutoff Membranes on Pro-Inflammatory Cytokine and Oxidative Marker Levels in Patients with Sepsis Who Developed Acute Kidney Injury. Blood Purif 2021; 51:772-779. [PMID: 34814149 DOI: 10.1159/000519881] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2021] [Accepted: 09/27/2021] [Indexed: 11/19/2022]
Abstract
INTRODUCTION There is insufficient data on the role of the medium cutoff (MCO) membranes in the clearance of pro-inflammatory cytokines and oxidant radicals in patients with sepsis requiring hemodialysis. METHODS The study consisted of 38 septic patients who developed acute kidney injury (AKI) and who were scheduled to undergo 2 sessions of hemodialysis. Nineteen patients underwent their first dialysis session with the MCO membrane and 19 patients with the high-flux (HF) membrane. In the second session, the membranes were switched. Pro-inflammatory cytokine and oxidative marker levels were measured in blood samples obtained before and after both dialysis sessions. Reduction ratios were compared for the 2 types of hemodialysis membranes. RESULTS After the first session, there was a greater reduction in tumor necrosis factor (TNF)-α with the MCO membrane (28.2 ± 21.1 vs. 8.0 ± 6.6, p = 0.001). After the second session, there was a greater reduction in interleukin (IL)-6 (27.8 ± 26.5 vs. 5.9 ± 13.3, p = 0.003) and IL-1β (20.5 ± 21.1 vs. 4.0 ± 6.5, p = 0.004) with the MCO membrane. When the first and second sessions of all 38 patients were compared, the reductions in TNF-α, IL-6, and IL-1β were consistently greater for MCO than HF (p = 0.001, p = 0.006, p < 0.001, respectively). The reductions in total antioxidant status, total oxidant status, and myeloperoxidase were not statistically different for the 2 types of dialysis membranes. CONCLUSIONS MCO membrane was superior to HF membrane in the removal of cytokines in septic patients with AKI. However, a similar effect was not observed for oxidative stress markers.
Collapse
Affiliation(s)
- Mustafa Comoglu
- Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara City Hospital, Ankara, Turkey
| | | | - Canan Topcuoglu
- Department of Biochemistry, Ankara City Hospital, Ankara, Turkey
| | - Osman Inan
- Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey
| | | | - Ihsan Ates
- Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey
| |
Collapse
|
7
|
Gungor S, Dede F, Can B, Keskin H, Aras M, Ones T, Erdil TY, Turoglu HT. The value of parathyroid scintigraphy on lesion detection in patients with normocalcemic primary hyperparathyroidism. Rev Esp Med Nucl Imagen Mol 2021; 41:S2253-654X(20)30196-7. [PMID: 34172427 DOI: 10.1016/j.remn.2020.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2020] [Revised: 09/22/2020] [Accepted: 09/24/2020] [Indexed: 12/01/2022]
Abstract
OBJECTIVE Primary hyperparathyroidism (PHPT) is one of the most frequent endocrine diseases. Most of the patients with PHPT are asymptomatic, and only 20% of them become symptomatic with increasing levels of calcium. It has been reported that normocalcemic primary hyperparathyroidism (NPHPT) may be the incipient period of PHPT where calcium (Ca) levels are in normal range, and it may advance to overt PHPT. Early diagnosis of PHPT is important in order to prevent its complications. In this retrospective study, we aimed to evaluate the role of 99mTc-MIBI parathyroid scintigraphy on lesion detection in patients with NPHPT. MATERIAL AND METHODS The parathyroid scintigraphy database was reviewed retrospectively in patients with PHPT. 117 patients who underwent 99mTc-MIBI scintigraphy were recruited to the study. Serum calcium level above 10.5mg/dl was considered as hypercalcemia. RESULTS A total of 117 patients' (female/male:98/19) mean serum PTH levels (mean±SD) were 149±97 pg/ml in normocalcemic group (Ca:9.6±0.6mg/dL, n:38) and 189±135 pg/ml in hypercalcemic group (Ca:11.4±0.6mg/dL, n:79) (p:0.072). The sex and ages were not different between the scintigraphy positive and negative groups, but the lesion detection rates with parathyroid scintigraphy were 42% in normocalcemic group and 81% in hypercalcemic group (p<0.0001). CONCLUSIONS Several factors including serum Ca, the imaging protocol, existence of multiglandular disease, the size and MIBI biokinetics of the adenoma may influence lesion detectability in parathyroid scintigraphy. Although high serum Ca level is an important parameter in predicting its success, parathyroid scintigraphy remains a valuable diagnostic method even in patients with NPHPT.
Collapse
Affiliation(s)
- S Gungor
- Department of Nuclear Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turquía.
| | - F Dede
- Department of Nuclear Medicine, Faculty of Medicine, Marmara University, Istanbul, Turquía
| | - B Can
- Department of Endocrinology and Metabolism, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turquía
| | - H Keskin
- Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turquía
| | - M Aras
- Department of Nuclear Medicine, Faculty of Medicine, Okan University, Istanbul, Turquía
| | - T Ones
- Department of Nuclear Medicine, Faculty of Medicine, Marmara University, Istanbul, Turquía
| | - T Y Erdil
- Department of Nuclear Medicine, Faculty of Medicine, Marmara University, Istanbul, Turquía
| | - H T Turoglu
- Department of Nuclear Medicine, Faculty of Medicine, Marmara University, Istanbul, Turquía
| |
Collapse
|
8
|
Turgut D, Piskinpasa SV, Keskin H, Agbaht K, Coskun Yenigun E, Dede F. Occult Adrenal Insufficiency in Renal Amyloidosis Patients. Medeni Med J 2021; 36:52-57. [PMID: 33828890 PMCID: PMC8020191 DOI: 10.5222/mmj.2021.93902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2021] [Accepted: 03/17/2021] [Indexed: 11/29/2022] Open
Abstract
Objective Systemic amyloidosis may affect many organs, and may cause endocrinologic problems which may result in adrenal insufficiency. However, assessment of adrenocortical reserve is challenging in amyloidosis patients with renal involvement. We aimed to evaluate adrenocortical reserve with various methods of cortisol measurement to determine any occult clinical condition. Methods Patients with renal amyloidosis and healthy subjects were evaluated in this cross-sectional study. Basal cortisol, corticosteroid-binding globulin (CBG), and albumin levels were measured. Serum free cortisol (cFC) level was calculated. Cortisol response tests performed after ACTH stimulation test (250 μg, intravenously) were evaluated, and free cortisol index (FCI) was calculated. Results Twenty renal amyloidosis patients, and 25 healthy control subjects were included in the study. Patients and control subjects had similar median serum baseline cortisol levels [258 (126-423) vs 350 (314-391) nmol/L, p=0.169)] whereas patients’ stimulated cortisol levels at the 60th minute were lower [624 (497-685) vs 743 (674-781) nmol/L, p=0.011)]. The 60th-minute total cortisol levels of 8 of the 20 (40%) amyloidosis patients were <500 nmol/L, but only three of these 8 patients had stimulated FCI <12 nmol/mg suggesting an adrenal insufficiency (15%). Conclusion ACTH stimulation test and cortisol measurements should be considered in renal amyloidosis patients with severe proteinuria to avoid false positive results if only ACTH stimulation test is used. It will be appropriate to evaluate this group of patients together with estimated measurements as FCI.
Collapse
Affiliation(s)
- Didem Turgut
- Baskent University Ankara Hospital, Department of Internal Medicine, Division of Nephrology, Ankara, Turkey
| | | | - Havva Keskin
- Istanbul Medeniyet University Goztepe Training and Research Hospital, Department of Internal Medicine, Istanbul, Turkey
| | - Kemal Agbaht
- Defne Hospital, Division of Endocrinology and Metabolism, Hatay, Turkey
| | - Ezgi Coskun Yenigun
- University of Health Sciences, Ankara Bilkent City Hospital, Division of Nephrology, Ankara, Turkey
| | - Fatih Dede
- University of Health Sciences, Ankara Bilkent City Hospital, Division of Nephrology, Ankara, Turkey
| |
Collapse
|
9
|
Ozcalik MS, Ates I, Demir BF, Dede F, Yilmaz N. Noninvasive Subclinical Atherosclerosis Indicator in a New Diagnosis of Primary Hypertension: Blood Pressure Index. Turk J Nephrol 2021. [DOI: 10.5152/turkjnephrol.2021.4183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
10
|
Arasan SN, Yenigun EC, Cevher SK, Dede F. Amlodipine Induced Massive Ascites, a Rare Clinical Case. Iran J Kidney Dis 2020; 14:517-519. [PMID: 33277458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/08/2019] [Accepted: 04/22/2020] [Indexed: 06/12/2023]
Abstract
INTRODUCTION Calcium channel blockers (CCBs) are commonly used agents in the treatment of hypertension as part of monotherapy or combination therapy. Peripheral edema is the most common side effect that requires discontinuation or replacement of treatment. Some studies in the literature have shown that long-acting dihydropyridine type CCBs lead chylous ascites in peritoneal dialysis patients. However, amlodipine-associated serous ascites cases are not available in the literature. CASE REPORT In this case report, we describe a rare case of amlodipine induced massive ascites in a 30-year-old male with renal transplantation. CONCLUSION We aimed to create awareness that pharmacologic causes should be considered in cases of ascites of unknown aetiology.
Collapse
Affiliation(s)
- Sema Nur Arasan
- University of Health Science, Ankara City Hospital, Department of Internal Medicine, Ankara, Turkey.
| | | | | | | |
Collapse
|
11
|
Sumnu A, Turkmen K, Cebeci E, Turkmen A, Eren N, Seyahi N, Oruc A, Dede F, Derici Ü, Basturk T, Şahin G, Sipahioglu M, Sahin GM, Tatar E, Dursun B, Sipahi S, Yılmaz M, Suleymanlar G, Ulu S, Gungor O, Kutlay S, Bahçebaşı ZB, Sahin İ, Kurultak I, Sevinc C, Yilmaz Z, Kazancioglu RT, Cavdar C, Candan F, Aydin Z, Oygar D, Gul B, Altun B, Paydas S, Uzun S, Istemihan Z, Ergul M, Dincer MT, Gullulu M, Piskinpasa S, Akcay OF, Unsal A, Koyuncu S, Gok M, Ozturk S. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group. Int Urol Nephrol 2020; 53:945-954. [PMID: 33155086 DOI: 10.1007/s11255-020-02690-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Accepted: 10/27/2020] [Indexed: 10/23/2022]
Abstract
PURPOSE Hematuria is one of the most common laboratory findings in nephrology practice. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular disease (PGD) patients with hematuria in our country. METHODS Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database between May 2009 and June 2019. The data of all PGD patients over the age of 16 years who were diagnosed with renal biopsy and had hematuria data were included in the study. Demographic characteristics, laboratory and biopsy findings were also recorded. RESULTS Data of 3394 PGD patients were included in the study. While 1699 (50.1%) patients had hematuria, 1695 (49.9%) patients did not have hematuria. Patients with hematuria had statistically higher systolic blood pressure, serum blood urea nitrogen, creatinine, albumin, levels and urine pyuria. However, these patients had statistically lower age, body mass index, presence of hypertension and diabetes, eGFR, 24-h proteinuria, serum total, HDL and LDL cholesterol, and C3 levels when compared with patients without hematuria. Hematuria was present 609 of 1733 patients (35.8%) among the patients presenting with nephrotic syndrome, while it was presented in 1090 of 1661 (64.2%) patients in non-nephrotics (p < 0.001). CONCLUSION This is the first multicenter national report regarding the demographic and histopathologic data of PGD patients with or without hematuria. Hematuria, a feature of nephritic syndrome, was found at a higher than expected in the PGDs presenting with nephrotic syndrome in our national database.
Collapse
Affiliation(s)
- Abdullah Sumnu
- Department of Nephrology, Medical Faculty, Medipol Mega Hastanesi, Medipol University, Göztepe Mahallesi Metin Sk. No: 4, Bağcılar, Istanbul, Turkey.
| | - Kultigin Turkmen
- Nephrology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
| | - Egemen Cebeci
- Nephrology, Haseki Training and Research Hospital, Istanbul, Turkey
| | - Aydin Turkmen
- Nephrology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
| | - Necmi Eren
- Nephrology Medical Faculty, Kocaeli University, İzmit, Kocaeli, Turkey
| | - Nurhan Seyahi
- Nephrology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
| | - Aysegul Oruc
- Nephrology, Medical Faculty, Uludag University, Bursa, Turkey
| | - Fatih Dede
- Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ülver Derici
- Nephrology, Medical Faculty, Gazi University, Ankara, Turkey
| | - Taner Basturk
- Nephrology, Hamidiye Sisli Etfal Training and Research Hospital, Istanbul, Turkey
| | - Garip Şahin
- Nephrology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Murat Sipahioglu
- Nephrology, Medical Faculty, Erciyes University, Kayseri, Turkey
| | - Gulizar Manga Sahin
- Nephrology, Sultan Abdulhamit Han Research and Training Hospital, Istanbul, Turkey
| | - Erhan Tatar
- Nephrology, Bozyaka Training and Research Hospital, Izmır, Turkey
| | - Belda Dursun
- Nephrology, Medical Faculty, Pamukkale University, Denizli, Turkey
| | - Savas Sipahi
- Nephrology, Medical Faculty, Sakarya University, Sakarya, Turkey
| | - Mürvet Yılmaz
- Nephrology, Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey
| | | | - Sena Ulu
- Nephrology, Medical Faculty, Afyon University, Afyon, Turkey
| | - Ozkan Gungor
- Nephrology, Medical Faculty, Sutcu İmam University, Kahramanmaras, Turkey
| | - Sim Kutlay
- Nephrology, İbni Sina Hospital, Medical Faculty, Ankara University, Ankara, Turkey
| | | | - İdris Sahin
- Nephrology, Medical Faculty, Inonu University, Malatya, Turkey
| | - Ilhan Kurultak
- Nephrology, Medical Faculty, Trakya University, Edirne, Turkey
| | - Can Sevinc
- Nephrology, Medical Faculty, Ataturk University, Erzurum, Turkey
| | | | | | - Caner Cavdar
- Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey
| | - Ferhan Candan
- Nephrology, Medical Faculty, Cumhuriyet University, Sivas, Turkey
| | - Zeki Aydin
- Nephrology, Darica Farabi Training and Research Hospital, Darıca, Kocaeli, Turkey
| | - Deren Oygar
- Nephrology, Burhan Nalbantoglu State Hospital, Lefkosa, Cyprus
| | - Bulent Gul
- Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, Nilüfer, Bursa, Turkey
| | - Bulent Altun
- Nephrology, Medical Faculty, Hacettepe University, Ankara, Turkey
| | - Saime Paydas
- Nephrology, Medical Faculty, Cukurova University, Adana, Turkey
| | - Sami Uzun
- Nephrology, Haseki Training and Research Hospital, Istanbul, Turkey
| | - Zulal Istemihan
- Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
| | - Metin Ergul
- Nephrology Medical Faculty, Kocaeli University, İzmit, Kocaeli, Turkey
| | - Mevlut Tamer Dincer
- Nephrology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
| | - Mustafa Gullulu
- Nephrology, Medical Faculty, Uludag University, Bursa, Turkey
| | - Serhan Piskinpasa
- Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | | | - Abdulkadir Unsal
- Nephrology, Hamidiye Sisli Etfal Training and Research Hospital, Istanbul, Turkey
| | - Sumeyra Koyuncu
- Nephrology, Medical Faculty, Erciyes University, Kayseri, Turkey
| | - Mahmut Gok
- Nephrology, Sultan Abdulhamit Han Research and Training Hospital, Istanbul, Turkey
| | - Savas Ozturk
- Nephrology, Haseki Training and Research Hospital, Istanbul, Turkey
| |
Collapse
|
12
|
Turgut D, Pişkinpaşa SV, Çoşkun Yenigün E, Aydemir N, Dede F. Urinay neutrophil gelatinase-associated lipocalin as a biomarker in different renal problems. Turk J Med Sci 2020; 50:1566-1572. [PMID: 32927927 PMCID: PMC7605094 DOI: 10.3906/sag-2002-130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Accepted: 09/08/2020] [Indexed: 11/18/2022] Open
Abstract
Background/aim Neutrophil gelatinase-associated lipocalin (NGAL) is used previously to estimate the etiology, severity, and clinical outcomes of acute kidney injury (AKI). However, the role of urinary NGAL (uNGAL) in the postrenal setting is not clear. In our study, we aimed to discover the cut-off value of uNGAL that can be used in the differential diagnosis of underlying AKI etiologies. Materials and methods In this prospective cross-sectional study, we examined 82 subjects in four groups: patients that had (1) postrenal AKI; (2) AKI other than postrenal etiologies; (3) stable chronic kidney disease; and (4) healthy subjects. A renal function assessment was carried out by measuring serum creatinine (sCr) and uNGAL at the time of diagnosis [0th min (T0)]. We followed the study group for three months. Results At the time of diagnosis, sCr (T0) was highest in the postrenal AKI and AKI groups in contrast to stable chronic kidney disease patients and healthy subjects (P < 0.001), as expected. T0 median uNGAL was highest in the postrenal group (P < 0.001). Area under curve (AUC) of uNGAL to estimate postrenal AKI presence was 0.957 (95% CI, 0.897–1.000; P < 0.001). The cut-off point of uNGAL was 42.625 ng/mL for this estimation. Conclusion Patients with AKI must be classified according to the underlying etiologies as soon as possible. uNGAL may be useful to estimate the etiologies, and whether the problem is acute or chronic in the course. In postrenal kidney problems, to plan the urgency of the urologic procedures, it is crucial.
Collapse
Affiliation(s)
- Didem Turgut
- Division of Nephrology, Department of Internal Medicine, Başkent University Ankara Hospital, Ankara, Turkey
| | | | - Ezgİ Çoşkun Yenigün
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Nihal Aydemir
- Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Hitit University, Çorum, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
13
|
Turgutalp K, Cebeci E, Turkmen A, Derici Ü, Seyahi N, Eren N, Dede F, Gullulu M, Basturk T, Manga Sahin G, Yılmaz M, Sipahi S, SAHIN G, Ulu MS, Tatar E, Gundogdu A, Turan Kazancioglu R, Sevinc C, Gungor O, Sahin İ, Kutlay S, Kurultak I, Aydin Z, Altun B, Dursun B, Yilmaz Z, Uzun O, Suleymanlar G, Candan F, Sezer S, Tanburoglu DB, Bicik Bahçebaşı Z, Guven Taymez D, Oygar D, Akcali E, Istemihan Z, Akcay OF, Dincer MT, Ergul M, Yenigun E, Turkmen K, Ozturk S. P0490IS THE SEVERITY OF GLOMERULAR IGG STAINING IN PATIENT WITH IGA NEPHROPATHY USEFUL FOR PREDICTING POOR RENAL PROGNOSIS? THE DATA FROM TSN-GOLD WORKING GROUP. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
In IgA nephropathy (IgAN), which is characterized by mesangial IgA accumulation, there is the formation of circulating autoantibodies against galactose deficient IgA1s (Gd-IgA1). IgG / Gd-IgA1 immunocomplexes accumulate in the glomerular mesangium and play a role in the pathogenesis of IgAN. Recent studies have suggested a relationship between glomerular IgG deposition and the severity of glomerular inflammation. However, detection of the presence and severity of IgG in routine immunofluorescence microscopy (IFM) may fail. This study aims to investigate whether IgG positivity detected by IFM is associated with poor renal prognostic indicators and whether renal prognosis can be predicted according to IgG positivity.
Method
4399 patients who were enrolled between May 2009-June 2019 in database of Turkish Society of Nephrology, Glomerular Diseases Working Group (TSN-GOLD) including 44 centers were evaluated. After exclusion criteria, 994 primary IgAN patients were included in the study. Glomerular IgG negative and positive patients were compared by means of Oxford classification scores, histopathological evaluations, proteinuria, creatinine, albumin, blood pressures. IgG positive patients were divided into subgroups according to the grade of the IFM positivity. The relationship between IgG positivity and poor prognosis criteria were evaluated.
Results
Demographic and biochemical findings of glomerular IgG positive and negative patients at the time of biopsy are shown in Table 1. No difference was found between the groups. There was no difference in the demographic and biochemical findings at the time of biopsy in IgG subgroup analyses (Table 2). There was no difference between the histopathological and Oxford MEST scores of the subgroups. Glomerular IgG positivity was not associated with diastolic blood pressure, systolic blood pressure, urea, uric acid, age, eGFR, albumin, proteinuria (p> 0.05 for all, r= -0.084, r= -0.102, r= -0.006, r=0.062, r= 0.014, r= -0.044, r= -0.061, r= -0.066, r= 0.150, respectively).
Conclusion
Glomerular IgG positivity detected by routine IFM in IgAN is not associated with poor renal prognostic indicators. It is difficult to predict renal prognosis by looking at the severity of IgG positivity at the baseline evaluation.
Collapse
Affiliation(s)
| | - Egemen Cebeci
- Haseki Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | - Aydin Turkmen
- Istanbul University, Department of Nephrology, Istanbul, Turkey
| | - Ülver Derici
- Gazi University Faculty of Medicine, Department of Nephrology, Ankara, Turkey
| | - Nurhan Seyahi
- Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Nephrology, Istanbul, Turkey
| | - Necmi Eren
- Kocaeli University, Department of Nephrology, Kocaeli, Turkey
| | - Fatih Dede
- Health Sciences University, Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey
| | - Mustafa Gullulu
- Uludag University Faculty of Medicine, Department of Medicine, Bursa, Turkey
| | - Taner Basturk
- Health Sciences University, Sıslı Hamidiye Etfal Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | - Gulizar Manga Sahin
- Istanbul Abdulhamid Han Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | - Mürvet Yılmaz
- Health Sciences University, Bakirkoy Sadi Konuk Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | - Savas Sipahi
- Sakarya University Medical Faculty Education and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | - Garip SAHIN
- Eskisehir Osmangazi University, Department of Nephrology, Istanbul, Turkey
| | - Memnune Sena Ulu
- Afyon Health Sciences University, Department of Nephrology, Afyon, Turkey
| | - Erhan Tatar
- Health Sciences University, Izmir Bozyaka Training and Research Hospital, Department of Nephrology, Izmir, Turkey
| | - Ali Gundogdu
- Erciyes University, Department of Nephrology, Kayseri, Turkey
| | | | - Can Sevinc
- Atatürk University, Department of Nephrology, Erzurum, Turkey
| | - Ozkan Gungor
- Kahramanmaras Sutcu Imam University, Department of Nephrology, Kahramanmaraş, Turkey
| | - İdris Sahin
- Inonu University Faculty of Medicine, Department of Nephrology, Malatya, Turkey
| | - Sim Kutlay
- Ankara University, School of Medicine, Department of Nephrology, Ankara, Turkey
| | - Ilhan Kurultak
- Trakya University, Department of Nephrology, Edirne, Turkey
| | - Zeki Aydin
- Darica Farabi Training and Research Hospital, Department of Nephrology, Kocaeli, Turkey
| | - Bulent Altun
- Hacettepe University, Department of Nephrology, Ankara, Turkey
| | - Belda Dursun
- Pamukkale University, Department of Nephrology, Denizli, Turkey
| | - Zulfikar Yilmaz
- Dicle University, Department of Nephrology, Diyarbakır, Turkey
| | - Ozcan Uzun
- Dokuz Eylül University, Department of Nephrology, İzmir, Turkey
| | | | - Ferhan Candan
- Cumhuriyet University, Department of Nephrology, Sivas, Turkey
| | - Siren Sezer
- Atilim University Medicana International Hospital, Department of Nephrology, Ankara, Turkey
| | | | - Zerrin Bicik Bahçebaşı
- Kartal Lutfi Kirdar Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| | | | - Deren Oygar
- Lefkosa BND Training and Research Hospital, Department of Nephrology, Lefkosa, Cyprus
| | - Esra Akcali
- Mersin University, Department of Nephrology, Mersin, Turkey
| | - Zulal Istemihan
- Istanbul University, Department of Nephrology, Istanbul, Turkey
| | - Omer Faruk Akcay
- Gazi University Faculty of Medicine, Department of Nephrology, Ankara, Turkey
| | - Mevlut Tamer Dincer
- Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Nephrology, Istanbul, Turkey
| | - Metin Ergul
- Kocaeli University, Department of Nephrology, Kocaeli, Turkey
| | - Ezgi Yenigun
- Health Sciences University, Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey
| | - Kultigin Turkmen
- Necmettin Erbakan University, Meram School of Medicine, Department of Internal Medicine, Division of Nephrology, Konya, Turkey
| | - Savas Ozturk
- Haseki Training and Research Hospital, Department of Nephrology, Istanbul, Turkey
| |
Collapse
|
14
|
Turkmen A, Sumnu A, Cebeci E, Yazici H, Eren N, Seyahi N, Dilek K, Dede F, Derici Ü, Unsal A, SAHIN G, Sipahioglu M, Gok M, Tatar E, Dursun B, Sipahi S, Yılmaz M, Suleymanlar G, Ulu MS, Gungor O, Kutlay S, Bicik Bahçebaşı Z, Sahin İ, Kurultak I, Turkmen K, Yilmaz Z, Turan Kazancioglu R, Cavdar C, Candan F, Aydin Z, Oygar D, Gul CB, Arici M, Paydas S, Guven Taymez D, Kucuk M, Trablus S, Turgutalp K, Koc L, Sezer S, Duranay M, Bardak S, Altintepe L, Arikan IH, Azak A, Odabas AR, Manga Sahin G, Ozturk S. P0501THE EPIDEMIOLOGICAL FEATURES OF PIRMARY GLOMERULAR DISEASES IN TURKEY: THE MULTICENTER STUDY OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES (TSN-GOLD) WORKING GROUP. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background and Aims
The largest data on the epidemiology of primary glomerular diseases (PGD) are obtained from the databases of countries or centers. Here, we presented the extended results of the Primary Glomerular Diseases Study of the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD)Working Group.
Method
The data of patients who underwent renal biopsy and diagnosed as primary glomerular disease were recorded in the database prepared for the study. Between May 2009 and May 2019, a total of 4399 patients from 47 centers were evaluated. Basal data of 3875 patients were analyzed after exclusion of those lacking light microscopy and immunofluorescence findings.
Results
The mean age was 41.5 ± 14.9 years. Of the patients, 1690 were female (43.6%) and 2180 (56.3%) were male. Nephrotic syndrome was the most common biopsy indication (51.7%). This was followed by asymptomatic urinary abnormalities (18.3%) and nephritic syndrome (17.8%). The most common PGH was IgA nephropathy (25.7%), followed by membranous nephropathy (25.6%) and FSGS (21.9%). The mean total number of glomeruli per biopsy was 17 ± 10. Mean baseline systolic blood pressure was 130 ± 20 mmHg and diastolic blood pressure was 81 ± 12 mmHg. Median proteinuria was 3300 (IQR: 1467-6307) mg / day, mean serum creatinine, estimated GFR and albumin values were 1.4 ± 1.5 mg / dl, 80.7 ± 39.1 ml / min and 3.2 ± 0.9 g / dl, respectively.
Conclusion
In Turkey, the incidence of IgA nephropathy patients have become more common than membranous nephropathy among PGD patients diagnosed with renal biopsy.
Collapse
Affiliation(s)
- Aydin Turkmen
- Istanbul University, Istanbul Faculty of Medicine, Nephrology, Istanbul, Turkey
| | - Abdullah Sumnu
- Medipol University Medical Faculty, Medipol Mega Hospital, Nephrology, İstanbul, Turkey
| | - Egemen Cebeci
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Halil Yazici
- Istanbul University, Istanbul Faculty of Medicine, Nephrology, Istanbul
| | - Necmi Eren
- Kocaeli University Medical Faculty, Nephrology, Kocaeli, Turkey
| | - Nurhan Seyahi
- Istanbul University, Cerrahpasa Faculty of Medicine, Nephrology, Istanbul, Turkey
| | - Kamil Dilek
- Uludag University, Medical Faculty, Nephrology, Bursa, Turkey
| | - Fatih Dede
- Ankara Numune Training and Research Hospital, Nephrology, Ankara, Turkey
| | - Ülver Derici
- Gazi University Medical Faculty, Nephrology, Ankara, Turkey
| | - Abdulkadir Unsal
- Hamidiye Sisli Etfal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Garip SAHIN
- Eskisehir Osmangazi University, Medical Faculty, Nephrology, Eskisehir, Turkey
| | - Murat Sipahioglu
- Erciyes University, Medical Faculty, Nephrology, Kayseri, Turkey
| | - Mahmut Gok
- Sultan Abdulhamit Han Research and Training Hospital, Nephrology, Istanbul, Turkey
| | - Erhan Tatar
- Bozyaka Training and Research Hospital, Nephrology, Izmır, Turkey
| | - Belda Dursun
- Pamukkale University, Medical Faculty, Nephrology, Denizli, Turkey
| | - Savaş Sipahi
- Sakarya University, Medical Faculty, Nephrology, Sakarya, Turkey
| | - Mürvet Yılmaz
- Bakirkoy Sadi Konuk Training and Research Hospital, Nephrology, Istanbul, Turkey
| | | | | | - Ozkan Gungor
- Sutcu İmam University, Medical Faculty, Nephrology, Kahramanmaras, Turkey
| | - Sim Kutlay
- Ankara University, Medical Faculty, İbni Sina Hospital, Nephrology, Ankara, Turkey
| | | | - İdris Sahin
- Inonu University, Medical Faculty, Nephrology, Malatya, Turkey
| | - Ilhan Kurultak
- Trakya University, Medical Faculty, Nephrology, Istanbul, Turkey
| | - Kultigin Turkmen
- Necmettin Erbakan University, Meram Medicine Faculty, Nephrology, Konya, Turkey
| | - Zulfikar Yilmaz
- Dicle University, Medical Faculty, Nephrology, Diyarbakir, Turkey
| | | | - Caner Cavdar
- Dokuz Eylul University, Medical Faculty, Nephrology, Izmir, Turkey
| | - Ferhan Candan
- Cumhuriyet University, Medical Faculty, Nephrology, Sivas, Turkey
| | - Zeki Aydin
- Darica Farabi Training and Research Hospital, Nephrology, Kocaeli, Turkey
| | - Deren Oygar
- Burhan Nalbantoglu State Hospital, Nephrology, Lefkosa, Cyprus
| | - Cuma Bulent Gul
- Bursa Yuksek Ihtisas Training and Research Hospital, Nephrology, Bursa, Turkey
| | - Mustafa Arici
- Hacettepe University, Medical Faculty, Nephrology, Ankara, Turkey
| | - Saime Paydas
- Cukurova University, Medical Faculty, Nephrology, Adana, Turkey
| | | | - Mehmet Kucuk
- Okmeydanı Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Sinan Trablus
- Istanbul Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Kenan Turgutalp
- Mersin University, Medical Faculty, Nephrology, Mersin, Turkey
| | - Leyla Koc
- Taksim Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Siren Sezer
- Atilim University, Medicana International Hospital, Nephrology, Ankara, Turkey
| | - Murat Duranay
- Ankara Training and Research Hospital, Nephrology, Ankara, Turkey
| | - Simge Bardak
- Batman State Hospital, Nephrology, Batman, Turkey
| | | | | | - Alper Azak
- Balikesir Training and Research Hospital, Nephrology, Balikesir, Turkey
| | - Ali Riza Odabas
- Medeniyet University Medical School, Goztepe Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Gulizar Manga Sahin
- Sultan Abdulhamit Han Research and Training Hospital, Nephrology, Istanbul, Turkey
| | - Savas Ozturk
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| |
Collapse
|
15
|
Eren N, Gursu M, Cebeci E, Turkmen A, Yeter HH, Seyahi N, Piskinpasa SV, Ersoy A, Basturk T, Manga Sahin G, Kocak Yucel FS, Genç AB, SAHIN G, Ulu MS, Soyhan M, Turkmen K, Ozberk S, Elcioğlu O, Altunoren O, Sahin İ, Kutlay S, Üstündağ S, Kalender B, Dede F, Altun B. P0440EPIDEMIOLOGICAL AND CLINICAL CHARACTERSTICS OF IGA NEPHROPATHY PATIENTS IN TURKEY: TSN-GOLD WORKING GROUP. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and Aims
According to the data of the Turkish Society of Nephrology-Glomerular Diseases Working Group (TSN-GOLD Working Group), IgA nephropathy is the most common primary glomerular disease in Turkey. The purpose of this study was to investigate the epidemiological and clinical data of IgA nephropathy patients in Turkey.
Method
4399 patients with primary glomerular diseases from 47 centers who were followed up between May 2009 and May 2019 were included in the study conducted by TSN-GOLD Working Group. 524 patients were excluded due to lack of pathological data. Among the remaining patients, demographic, clinical and laboratory data of 994 patients with IgA nephropathy were analyzed.
Results
The median age of the patients was 37 (28-47) years, and 37.3% of them were female. The laboratory and clinical data at the time of diagnosis is presented in Figure-1, and biopsy indications are described in Figure-2. The median number of glomeruli was 16 (IQR: 3.5-4.3), sclerotic glomeruli was 2 (IQR: 1-5), and segmental sclerotic glomeruli was 1 (IQR: 1-2). Exudative changes, subendothelial and subepithelial deposition were present in 566 patients (56.9%), 46 patients (4.6%) and in 38 patients (3.8%), respectively. 662 (66.1%) and 611 of the patients (61.4%) had tubular atrophy and interstitial fibrosis in varying degrees, respectively. 672 (%67.6) and 416 patients (%41.9) had interstitial inflammation and vascular changes, respectively. In immunofluorescence staining, 18%, 30.1%, 4.4%, 68% of the patients had IgG, IgM, C1q and C3 positivity, respectively. Crescentic glomeruli were detected in 227 patients (3.3 ± 3.1 glomeruli). Patients with crescentic glomeruli had significantly higher proteinuria and lower eGFR than the patients without [2203 mg/day (15-26078) vs 1807 mg/day (15-29112); p=0.001; 55.3 ml/min/1.73 m2 (3.72-141.9) vs 72 ml/min/1.73 m2 (3.84-150.81); p<0.001, respectively]. Oxford classification was applied to 544 patients. Endocapillary hypercellularity (E1), mesengial hypercellularity (M1), tubular atrophy and interstitial fibrosis (T1 and T2), segmental sclerosis (S1) were present in 126 (13%), 425 (42.8%), 306 (30.8%) and 325 patients (%32.7), respectively. Proteinuria levels were higher in patients with endocapillary hypertrophy, mesengial hypercellularity, tubular atrophy-interstitial fibrosis and segmental sclerosis. eGFR levels were lower in patients with endocapillary hypertrophy, tubular atrophy-interstitial fibrosis and segmental sclerosis (Figure-3).
Conclusion
In this study we found that, the most common presentation of IgA nephropathy patients in our country was asymptomatic urinary abnormalities followed by nephritic and nephrotic syndrome. Higher proteinuria and lower eGFR values in patients with crescentic glomeruli, support the adoption of crescentic lesions in the new Oxford classification (MEST-C) to predict more precise outcome of IgA nephropathy patients. The high number of patients to whom the Oxford classification was applied provided us with the opportunity to examine the clinical reflections of pathological features. Evaluation of the follow-up data of the patients will give us the possibility to reveal the effect of initial clinical and pathological features on clinical findings and renal outcome.
Collapse
Affiliation(s)
- Necmi Eren
- Kocaeli University, Faculty of Medicine, Division of Nephrology, Kocaeli, Turkey
| | - Meltem Gursu
- Bezmialem Vakif University, Faculty of Medicine, Division of Nephrology, Istanbul, Turkey
| | - Egemen Cebeci
- Haseki Training and Research Hospital, Division of Nephrology, Istanbul, Turkey
| | - Aydin Turkmen
- İstanbul University, İstanbul Medical Faculty, Division of Nephrology, Istanbul, Turkey
| | - Hasan Haci Yeter
- Gazi University, Faculty of Medicine, Division of Nephrology, Ankara, Turkey
| | - Nurhan Seyahi
- İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Division of Nephrology, Istanbul, Turkey
| | | | - Alpaslan Ersoy
- Uludağ University Faculty of Medicine, Division of Nephrology, Bursa, Turkey
| | - Taner Basturk
- Şişli Etfal Training and Research Hospital, Division of Nephrology, Istanbul, Turkey
| | - Gulizar Manga Sahin
- Sultan Abdülhamid Han, Training and Research Hospital, Division of Nephrology, Istanbul, Turkey
| | | | - Ahmed Bilal Genç
- Sakarya University, Faculty of Medicine, Division of Nephrology, Adapazari, Turkey
| | - Garip SAHIN
- Eskişehir Osmangazi University, Faculty of Medicine, Division of Nephrology, Eskisehir, Turkey
| | - Memnune Sena Ulu
- Afyon Saglik Bilimleri University, Faculty of Medicine, Division of Nephrology, Afyonkarahisar, Turkey
| | - Merve Soyhan
- Bozyaka Training and Research Hospital, Division of Nephrology, Izmir, Turkey
| | - Kultigin Turkmen
- Necmettin Erbakan Üniversity, Meram Medical Faculty, Division of Nephrology, Konya, Turkey
| | - Sumeyra Ozberk
- Erciyes University, Faculty of Medicine, Division of Nephrology, Kayseri, Turkey
| | - Omer Elcioğlu
- Bezmialem Vakif University, Faculty of Medicine, Division of Nephrology, Istanbul, Turkey
| | - Orcun Altunoren
- Kahramanmaras Sutcu Imam University, Faculty of Medicine, Division of Nephrology, Kahramanmaras, Turkey
| | - İdris Sahin
- Inonü University, Faculty of Medicine, Division of Nephrology, Malatya, Turkey
| | - Sim Kutlay
- Ankara University, Faculty of Medicine, Division of Nephrology, Ankara, Turkey
| | - Sedat Üstündağ
- Trakya University, Faculty of Medicine, Division of Nephrology, Edirne, Turkey
| | - Betul Kalender
- Kocaeli University, Faculty of Medicine, Division Of Nephrology, Kocaeli, Turkey
| | - Fatih Dede
- Ankara Numune Training and Research Hospital, Division of Nephrology , Ankara, Turkey
| | - Bulent Altun
- Hacettepe University, Faculty of Medicine, Division of Nephrology, Ankara, Turkey
| |
Collapse
|
16
|
Sumnu A, Turkmen K, Cebeci E, Turkmen A, Eren N, Seyahi N, Oruc A, Dede F, Derici Ü, Basturk T, SAHIN G, Sipahioglu M, Manga Sahin G, Tatar E, Dursun B, Sipahi S, Yılmaz M, Suleymanlar G, Ulu MS, Gungor O, Kutlay S, Bicik Bahçebaşı Z, Sahin İ, Kurultak I, Sevinc C, Yilmaz Z, Turan Kazancioglu R, Cavdar C, Candan F, Aydin Z, Oygar D, Gul CB, Altun B, Paydas S, Uzun S, Istemihan Z, Ergul M, Dincer MT, Gullulu M, Piskinpasa SV, Akcay OF, Unsal A, Koyuncu S, Gok M, Ozturk S. P0448CHARACTERISTICS OF PRIMARY GLOMERULAR DISEASE PATIENTS WITH HEMATURIA IN TURKEY: THE DATA FROM TSN-GOLD WORKING GROUP. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Hematuria is one of the most common laboratory findings in nephrology practice. In different regions of the world, the etiologic causes differ. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular diseases (PGD) patients with hematuria in our country.
Method
Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database between May 2009 and June 2019. The data of all PGD patients over the age of 16 years who were diagnosed with renal biopsy and had hematuria data were included in the study. The biopsy samples were processed using a light microscopy and immunofluorescence examination. Demographic characteristics such as age, sex, indications for biopsy, primary glomerular diseases, comorbidities, laboratory and biopsy findings of all patients were also recorded. Hematuria was defined as the presence of at least 5 red blood cells/hpf.
Results
Data of 3394 patients were included to the study after the exclusion of patients with secondary glomerulonephritis and patients with missing biopsy findings. While 1699 (50.1%) patients had hematuria, 1695 (49.9%) patients did not have hematuria. Demographic, laboratory, and histopathological characteristics of patients with and without hematuria are given in Table. Patients with hematuria had statistically higher systolic blood pressure (SBP), serum blood urea nitrogen, creatinine, albumin, levels and urine pyuria, however, these patients had statistically lower age, body mass index, presence of hypertension and diabetes, eGFR, 24-hour proteinuria, serum total, HDL and LDL-cholesterol and C3 levels when compared with patients without hematuria. Figure depicted the etiologic causes of patients with and without hematuria. According to histopathological findings, number of global sclerotic glomeruli, cellular and fibrocellular crescents, the levels of mesangial proliferation, endocapillary proliferation, exudative changes in glomeruli, severe tubular atrophy, interstitial inflammation, subendothelial deposition, moderate and severe IgA and C3 deposition were found to be significantly higher and the levels of basal membrane thickening, interstitial fibrosis, subepithelial deposition, severe IgG staining were found to be significantly lower in patients with hematuria.
Conclusion
This is the first multicenter national report regarding the demographic and histopathologic data of PGD patients with or without hematuria. Hematuria, a feature of nephritic syndrome, was found at a higher than expected in the PGDs presenting with nephrotic syndrome in our national database.
Collapse
Affiliation(s)
- Abdullah Sumnu
- Medipol University, Medical Faculty, Nephrology, Istanbul, Turkey
| | - Kultigin Turkmen
- Necmettin Erbakan University, Meram Medical Faculty, Nephrology, Konya, Turkey
| | - Egemen Cebeci
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Aydin Turkmen
- Istanbul University, Istanbul Medical Faculty, Nephrology, Istanbul, Turkey
| | - Necmi Eren
- Kocaeli University, Medical Faculty, Nephrology, Kocaeli, Turkey
| | - Nurhan Seyahi
- Istanbul University, Cerrahpasa Medical Faculty, Nephrology, Istanbul, Turkey
| | - Aysegul Oruc
- Uludag University, Medical Faculty, Nephrology, Bursa, Turkey
| | - Fatih Dede
- Ankara Numune Training and Research Hospital, Nephrology, Ankara, Turkey
| | - Ülver Derici
- Gazi University, Medical Faculty, Nephrology, Ankara, Turkey
| | - Taner Basturk
- Hamidiye Sisli Etfal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Garip SAHIN
- Eskisehir Osmangazi University, Medical Faculty, Nephrology, Eskisehir, Turkey
| | - Murat Sipahioglu
- Erciyes University, Medical Faculty, Nephrology, Kayseri, Turkey
| | - Gulizar Manga Sahin
- Sultan Abdulhamit Han Research and Training Hospital, Nephrology, Istanbul, Turkey
| | - Erhan Tatar
- Bozyaka Training and Research Hospital, Nephrology, Izmır, Turkey
| | - Belda Dursun
- Pamukkale University, Medical Faculty, Nephrology, Denizli, Turkey
| | - Savas Sipahi
- Sakarya University, Medical Faculty, Nephrology, Sakarya, Turkey
| | - Mürvet Yılmaz
- Bakirkoy Sadi Konuk Training and Research Hospital, Nephrology, Istanbul, Turkey
| | | | | | - Ozkan Gungor
- Sutcu İmam University, Medical Faculty, Nephrology, Kahramanmaras, Turkey
| | - Sim Kutlay
- Ankara University, Medical Faculty, İbni Sina Hospital, Nephrology, Ankara, Turkey
| | | | - İdris Sahin
- Inonu University, Medical Faculty, Nephrology, Malatya, Turkey
| | - Ilhan Kurultak
- Trakya University, Medical Faculty, Nephrology, Edirne, Turkey
| | - Can Sevinc
- Ataturk University, Medical Faculty, Nephrology, Erzurum, Turkey
| | - Zulfikar Yilmaz
- Dicle University, Medical Faculty, Nephrology, Diyarbakir, Turkey
| | | | - Caner Cavdar
- Dokuz Eylul University, Medical Faculty, Nephrology, Izmir, Turkey
| | - Ferhan Candan
- Cumhuriyet University, Medical Faculty, Nephrology, Sivas, Turkey
| | - Zeki Aydin
- Darica Farabi Training and Research Hospital, Nephrology, Kocaeli, Turkey
| | - Deren Oygar
- Burhan Nalbantoglu State Hospital, Nephrology, Lefkosa, Cyprus
| | - Cuma Bulent Gul
- Bursa Yuksek Ihtisas Training and Research Hospital, Nephrology, Bursa, Turkey
| | - Bulent Altun
- Hacettepe University, Medical Faculty, Nephrology, Ankara, Turkey
| | - Saime Paydas
- Cukurova University, Medical Faculty, Nephrology, Adana, Turkey
| | - Sami Uzun
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Zulal Istemihan
- Istanbul University, Istanbul Medical Faculty, Internal Medicine, Istanbul, Turkey
| | - Metin Ergul
- Kocaeli University, Medical Faculty, Nephrology, Kocaeli, Turkey
| | - Mevlut Tamer Dincer
- Istanbul University, Cerrahpasa Medical Faculty, Nephrology, Istanbul, Turkey
| | - Mustafa Gullulu
- Uludag University, Medical Faculty, Nephrology, Bursa, Turkey
| | | | | | - Abdulkadir Unsal
- Hamidiye Sisli Etfal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Sumeyra Koyuncu
- Erciyes University, Medical Faculty, Nephrology, Kayseri, Turkey
| | - Mahmut Gok
- Sultan Abdulhamit Han Research and Training Hospital, Nephrology, Istanbul, Turkey
| | - Savas Ozturk
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| |
Collapse
|
17
|
Gul CB, Kucuk M, Ozturk S, Demir E, Eren N, Sumnu A, Seyahi N, Gullulu M, Dede F, Derici Ü, Koc Y, SAHIN G, Oymak O, Manga Sahin G, Tatar E, Dursun B, Dheir H, Apaydin S, Suleymanlar G, Ulu MS, Altunoren O, Kutlay S, Mese M, Sahin İ, Ustundag S, Turkmen K, Yilmaz ME, Turan Kazancioglu R, Uzun O, Candan F, Aydin Z, Oygar D, Aktas N, Erdem Y, Paydas S, Guven Taymez D, Can B, Kıykım A, Koc L, Sezer S, Duranay M, Bardak S, Altintepe L, Kaya B, Azak A, Alisir Ecder S, Cavdar C, Selcuk NY. P0431TRENDS OF PRIMARY GLOMERULAR DISEASE IN TURKEY FROM 2009 TO 2017: A REGIONAL REGISTRY REPORT FROM TSN-GOLD WORKING GROUP. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background and Aims
Several glomerular disease registries in Europe, and they shared their data; however, there was a lack of current data on trends of primary glomerulopathy in Turkey. Glomerular disease patterns can change geographical areas and populations decade by decade. Our aim is to present Turkey's primary glomerular disease pattern from 2009 to 2017.
Method
3878 native kidney biopsy records were assessed in the Turkish Society of Nephrology Glomerulopathy (TSN-GOLD) Working Group Registry. Secondary disease (lupus, etc.) and transplant biopsies do not enroll in the registry. These records divided into four periods, before 2009, 2009 to 2013, 2013 to 2017, and 2017 to current.
Results
A total of 3858 patients (M = 2173, K = 1685) were examined. There was no difference in the distribution of number of patients according to periods (Q1 = 968, Q2 = 960, Q3 = 968, Q4 = 962). Nephrotic syndrome was the most common biopsy indication in all quarters (58.6%, 53%, 44.1%, 51.6%, respectively). Glomerulopathy types; Membranous GN (29.9%, n = 290) was the first in Q1 and IgA nephropathy (17.7%, n = 172) was the second. IgA nephropathy (28.5%, n = 274) was the most common glomerulopathy in Q2, while Membranous GN (25.5%, n = 245) was the second most common. IgA nephropathy (29.9%, n = 285) was the most common glomerulopathy in Q3, followed by FSGS (22.9%, n = 222) and Membranous GN. In Q4, FSGS (26.8, n = 258) was the most common glomerulopathy, followed by IgA nephropathy (26.7%, n = 257) and Membranous GN (24.5%, n = 236) (Figure 1).
Conclusion
While biopsy indications did not change over the years, the incidence of FSGS and IgA nephropathy gradually increased.
Collapse
Affiliation(s)
- Cuma Bulent Gul
- Bursa Yuksek Ihtisas Training and Research Hospital, Nephrology, Bursa, Turkey
| | - Mehmet Kucuk
- Okmeydanı Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Savas Ozturk
- Haseki Training and Resarch Hospital, Nephrology, Turkey
| | - Erol Demir
- Istanbul University Medical School, Nephrology
| | - Necmi Eren
- Kocaeli Derince Training and Research Hospital, Nephrology
| | - Abdullah Sumnu
- Medipol Mega University Hospital, Nephrology, istanbul, Turkey
| | | | - Mustafa Gullulu
- Uludag University Medical Faculty Hospital, Nephrology, Bursa, Turkey
| | - Fatih Dede
- Ankara Numune Training and Research Hospital, Nephrology, ankara, Turkey
| | - Ülver Derici
- Gazi University Medical Faculty, Nephrology, Ankara, Turkey
| | - Yener Koc
- Sisli Hamidiye Training and Research Hospital, Nephrology, Turkey
| | - Garip SAHIN
- Osmangazi University, Nephrology, eskisehir, Turkey
| | - Oktay Oymak
- Erciyes University, Nephrology, Kayseri, Turkey
| | | | - Erhan Tatar
- Bozyaka Training and Research Hospital, Nephrology, Izmir, Turkey
| | | | - Hamad Dheir
- Sakarya Training and Research Hospital, Nephrology, Turkey
| | - Süheyla Apaydin
- Dr. Sadi Konuk training and reseasrch hospital, Istanbul, Turkey
| | | | - Memnune Sena Ulu
- Afyon Kocatepe University Medical School, nephrology, Afyonkarahisar, Turkey
| | - Orcun Altunoren
- Kahramanmaraş Sütçü İmam University, Nephrology, Kahramanmaras, Turkey
| | - Sim Kutlay
- Ibn Sina University Hospital, Nephrology, Ankara, Turkey
| | - Meral Mese
- Kartal Training and Research Hospital, Nephrology, Turkey
| | - İdris Sahin
- Inonu University Medical School, Nephrology, Turkey
| | | | - Kultigin Turkmen
- Necmettin Erbakan University Meram Medical School, Nephrology, Turkey
| | | | | | - Ozcan Uzun
- Dokuz Eylul University Medical school, Nephrology, Turkey
| | - Ferhan Candan
- Cumhuriyet University Medical School, Nephrology, Turkey
| | - Zeki Aydin
- Darıca Farabi Training and Research Hospital, Nephrology, Turkey
| | - Deren Oygar
- Lefkosa Burhan Nalbantoglu Hospital, Nephrology
| | - Nimet Aktas
- Bursa Yuksek Ihtisas Training and Research Hospital, Nephrology, Bursa, Turkey
| | - Yunus Erdem
- Hacettepe University Medical School, Nephrology, Turkey
| | | | | | - Basak Can
- Ok Meydanı Traing and Research Hospital, Nephrology
| | | | - Leyla Koc
- Taksim Traing and Research Hospital, Nephrology
| | - Siren Sezer
- Baskent University Medical School, Nephrology
| | | | | | | | - Burcu Kaya
- Marmara University Medical School, Nephrology, Turkey
| | - Alper Azak
- Balıkesir Traing and Research Hospital, Nephrology
| | | | - Caner Cavdar
- Dokuz Eylul University Medical School, Nephrology
| | | |
Collapse
|
18
|
Aydin Z, Turkmen K, Dede F, Yasar E, Ozturk S, Aydin M, Tatar E, SAHIN G, Manga Sahin G, Oto OA, Sumnu A, Eroglu E, Dincer MT, Dursun B, Eren N, Sevinc M, Guzel FB, Yalin SF, Kutlay S, Apaydin S, Berktas HB, Kazan S, Dheir H, Bora F, Basturk T, Sahin İ. P0395DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS IN TURKEY. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Rapidly progressive glomerulonephritis (RPGN) is a clinical condition that develops due to different etiologic causes, characterized by a rapid and progressive decrease in renal function and progresses to end-stage renal failure in weeks to months if not treated. In our study, diagnostic and demographic characteristics of patients diagnosed with RPGN by biopsy, clinical and laboratory findings in our country were investigated.
Method
Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) Working Group database between May 2009 and June 2019. Demographic characteristics such as age, sex, indications for biopsy, diagnosis of the glomerular diseases, comorbidities, laboratory and biopsy findings of all patients were recorded. The data presented is cross-sectional and includes application data for the biopsy period. According to their types, RPGN patients were classified as type 1 (anti-GBM related), type 2 (immunocomplex related) and type 3 (immune-negative; “pauci-immune”).
Results
After exclusion of 46 patients with missing data, 200 patients (mean age 47.9 ± 16.7 years, 44% female) were included in the study which constitutes 5.2% of the total glomerulonephritis database (total number of patients: 3875). Hypertension was present in 62 patients (31.0%) and diabetes was present in 18 patients (9.0%). Renal biopsy was performed in 147 (73.5%) patients due to nephritic syndrome (RPGN included). 80.2% of the patients' biopsies were performed in nephrology clinics and 19.8% of them were performed in radiology clinics. ANCA positivity was found in 121 (60.5%) patients (proteinase 3-ANCA was positive in 55 and myeloperoxidase-ANCA positive in 66 patients). Type 1 RPGN was detected in 11 (5.5%), type 2 RPGN in 42 (21%) and type 3 RPGN in 147 (73.5%) patients. In 21 patients (10.5%), biopsy revealed RPGN with advanced chronic changes (fibrous global sclerotic glomeruli, advanced interstitial fibrosis and tubular atrophy). Mean serum creatinine was 4.2 ± 3.4 mg/dl, median glomerular filtration rate was 18 (10-37) ml/min and proteinuria 2100 (1229-3526) mg/day according to CKD-EPI formula. The mean number of glomeruli in the biopsies was 18.8 ± 10.6 and the number of crescentic glomeruli was 9.9 ± 7.7 (ratio: 52.7%) (Figure). The patients were divided into 3 groups according to their crescentic glomeruli ratios. The proportion of crescentic glomeruli is 10-50% in group 1, 50-80% in group 2, and >80% in group 3. The demographic, laboratory and histopathological characteristics of the groups are given in Figure. It was observed that urea and creatinine increased and calcium and hemoglobin decreased with increasing crescentic glomerular ratio.
Conclusion
Our study provides valuable demographic, clinical, laboratory and histopathological data about RPGN in our country. Our data are generally compatible with the literature. In our study, advanced chronic histopathological findings were prominent in the biopsy of 21 patients. Early biopsy should be performed to confirm the diagnosis of RPGN and to avoid unnecessary intensive immunosuppressive therapy. In addition to the treatments applied, detailed data, including patient and renal survival are needed.
Collapse
Affiliation(s)
- Zeki Aydin
- Darica Farabi Training and Research Hospital, Nephrology, Kocaeli, Turkey
| | - Kultigin Turkmen
- Necmettin Erbakan University, Meram Medical School, Nephrology, Turkey
| | - Fatih Dede
- Ankara Numune Training and Research Hospital, Nephrology, Ankara, Turkey
| | - Emre Yasar
- Gazi University Medical School, Nephrology, Ankara, Turkey
| | - Savas Ozturk
- Haseki Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Mehmet Aydin
- Uludag University Medical School, Nephrology, Bursa, Turkey
| | - Erhan Tatar
- Bozyaka Training and Research Hospital, Nephrology, Izmir, Turkey
| | - Garip SAHIN
- Osmangazi University Medical School, Nephrology, Eskisehir, Turkey
| | - Gulizar Manga Sahin
- Sultan Abdülhamid Han Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Ozgur Akin Oto
- Istanbul University Medical School, Nephrology, Istanbul, Turkey
| | - Abdullah Sumnu
- Medipol University Medical School, Nephrology, Istanbul, Turkey
| | - Eray Eroglu
- Erciyes University Medical School, Nephrology, Kayseri, Turkey
| | | | - Belda Dursun
- Pamukkale University Medical School, Nephrology, Denizli, Turkey
| | - Necmi Eren
- Kocaeli University Medical School, Nephrology, Kocaeli, Turkey
| | - Mustafa Sevinc
- Sisli Hamidiye Etfal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Fatma Betul Guzel
- Sutcu Imam University Medical School, Nephrology, Kahramanmaraş, Turkey
| | - Serkan Feyyaz Yalin
- Dr Lutfi Kırdar Kartal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - Sim Kutlay
- Ankara University Medical School, Nephrology, Ankara, Turkey
| | - Suheyla Apaydin
- Bakirkoy Dr Sadi Konuk Training and Research Hospital, Nephrology, Istanbul, Turkey
| | | | - Sinan Kazan
- Afyonkarahisar SBU Medical School, Nephrology, Afyonkarahisar, Turkey
| | - Hamad Dheir
- Sakarya University Medical School, Nephrology, Sakarya, Turkey
| | - Feyza Bora
- Akdeniz University Medical School, Nephrology, Antalya, Turkey
| | - Taner Basturk
- Sisli Hamidiye Etfal Training and Research Hospital, Nephrology, Istanbul, Turkey
| | - İdris Sahin
- Inonu University Medical School, Nephrology, Malatya, Turkey
| |
Collapse
|
19
|
Abstract
BACKGROUND Blood from patients who are receiving anticoagulant therapy may take longer to clot. Anticoagulation is an important component of the dialysis prescription. We compared BD Vacutainer® Barricor™ Plasma Blood Collection Tubes (BD BarrricorTM), BD Vacutainer® PST™ Lithium Heparin Tubes (BD PST™), and BD (Becton-Dickinson, Franklin Lakes, NJ, USA) Vacutainer Serum Separator Tubes (BD SST), as reference tube in dialysis patients to examine whether they had an effect on routine biochemical tests. MATERIALS AND METHODS A total of 29 chronic hemodialysis patients were included in this study. Samples were collected into BD BarrricorTM, BD PST™, and BD SST tubes after the dialysis. All the tubes were centrifuged by NF 1200R rotor (1,300 g for 10 minutes at 22°C, 1,200 g for 10 minutes at 4°C, 2,400 g for 10 minutes at 22°C, respectively) after the incubation period. Eleven routine clinical chemistry parameters (Creatinine, Urea, Na, K, Cl, AST, ALT, Total Bilirubin, Direct Bilirubin, Calcium, Cholesterol) were analyzed on a Beckman Coulter AU 5800. RESULTS Results of creatinine, K and cholesterol were statistically significantly different between the SST and LiH (p = 0.014, p = 0.009, and p < 0.001, respectively). In terms of other biochemical parameters we tested for all three tubes there was no clinically significance inspite of the statistically significance. CONCLUSIONS BD Barricor™ tubes provide fast, clean, high-quality plasma samples, safe results, and may lower times and costs.
Collapse
|
20
|
Turgut D, Colak A, Koksal Cevher S, Coskun Yenigun E, Dede F. SUN-381 GLOMERULAR AREA İN PRİMARY GLOMERULAR DİSEASES. Kidney Int Rep 2020. [DOI: 10.1016/j.ekir.2020.02.920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
21
|
Kösem A, Topçuoğlu C, Sezer S, Köksal Cevher Ş, Coşkun Yenigün E, Dede F, Turhan T. Comparison of some biochemical tests in different blood collection tubes in hemodialysis patients. Turkish Journal of Biochemistry 2020. [DOI: 10.1515/tjb-2018-0341] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Objective
Blood collection tubes (BCTs) related interferences in test results can adversely influence on patient outcomes. We compared test results of samples in BD (Becton-Dickinson, Franklin Lakes, NJ, USA) Vacutainer Serum Separator Tubes (SST), BD Vacutainer® Barricor™ Plasma BCTs (Barricor™) and BD Vacutainer® Rapid Serum Tube (RST).
Materials and methods
Thirty-two samples were obtained from patients after the hemodialysis were included in this study. Eight routine clinical chemistry parameters (AST, creatinin, urea, PTH, glucose, LDH, K, calcium) were measured on Roche Cobas Analyzer (Roche Diagnostics, North America). The results of samples obtained from RST and Barricor™ were compared with SST as reference tubes.
Results
Results of Glucose, K, Urea, PTH from the SST and Barricor™ were statistically significantly different (p = 0.017, p < 0.001, p = 0.011, p < 0.001, respectively). In addition, results of PTH, LDH from SST and RST were significantly different (p < 0.001, p = 0.019). However, statistical significance of test results was not clinically significant for the biochemical parameters.
Conclusion
Working with Barricor™ may provide not just a fast, clean, high-quality plasma samples, safety results, but also time and cost-effectivity. Therefore, these types of tubes, which are less costly than other BCTs, may be preferred to obtain plasma.
Collapse
|
22
|
Turgut D, Coskun Yenigun E, Kundi H, Ozkayar N, Dede F. Subclinical Cardiovascular Risk Factors in Chronic Kidney Disease: Abnormal Heart Rate Recovery. Turk J Nephrol 2020. [DOI: 10.5152/turkjnephrol.2020.3633] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
23
|
Ağadayı E, Dede F, Coşkun Yenigün E, Köksal Cevher Ş, Şencan İ, Özkara A. Hemodiyaliz sırasında gerçekleştirilen sanatsal ve sosyal faaliyetlerin hastaların yaşam kalitesi, ağrı, kaygı durumları ve intradiyalitik komplikasyonlar üzerindeki etkileri. FAMILY PRACTICE AND PALLIATIVE CARE 2019. [DOI: 10.22391/fppc.472173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
24
|
Koksal Cevher S, Hasan TK, Ozden SO, Coskun Yenigun E, Dede F. SP169THE EFFECT OF PROTEINURIA ON THE GALLBLADDER MOTILITY: A SINGLE CENTER EXPERIENCE. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Simal Koksal Cevher
- Health Sciences University, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Tankut Koseoglu Hasan
- Health Sciences University, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Sabri Onur Ozden
- Health Sciences University, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Ezgi Coskun Yenigun
- Health Sciences University, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Fatih Dede
- Health Sciences University, Ankara Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
25
|
Gümüştakım RŞ, Ozkara A, Kahveci R, Döner Güner P, Ayhan Başer D, Dede F. Awareness, Treatment and Control Rates of Hypertensive Patients in Ankara. Euras J Fam Med 2019. [DOI: 10.33880/ejfm.2019080103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Aim: It was aimed to evaluate the awareness levels of patients about hypertension, treatment and control rates.
Methods: The descriptive study included 203 patients between ages of 35–80 with a previous diagnosis of hypertension to the primary care outpatient clinic of Ankara Numune Training and Research Hospital in September 2011-January 2012. A 42-item questionnaire was used and 19 questions were used to determine the level of awareness among them. Nine measurements were in the office by the researcher and 12 measurements at home by the patient.
Results: 25.6% of the patients were males and 74.4% were females. The median age was 59 years (IQR=13). The section for scoring the awareness levels revealed following: 27.1% of patients were non-aware, 58.6% had a low level of awareness and 14.3% had a high level of awareness. 72.9% of the patients were aware, 93.1% were taking antihypertensive treatment, while 42.4% measured blood pressures both at home and at office are under control. Awareness level is related to diet, exercise, education, salt usage, blood pressure measurement frequency, doctor referral frequency, education and knowledge level about hypertension, blood pressure monitoring branch, antihypertensive treatment status, hypertension duration, number of antihypertensive drugs and regular usage rates; but hypertension control was only associated with salt use, antihypertensive treatment and number of antihypertensive drugs.
Conclusion: Hypertension is a common problem in our country and as we have seen in our studies, awareness rates are insufficient. Although the treatment rates are high, the control rates are not sufficient. This suggests that patients' compliance with treatment is not at the desired level. The most important thing to do in this regard is to raise awareness by increasing public awareness about hypertension. In this respect, primary care physicians have a great responsibility.
Collapse
Affiliation(s)
| | - Adem Ozkara
- Department of Family Medicine, Ankara Numune Training and Research Hospital
| | - Rabia Kahveci
- Department of Family Medicine, Ankara Numune Training and Research Hospital
| | | | - Duygu Ayhan Başer
- Department of Family Medicine, Hacettepe University School of Medicine
| | - Fatih Dede
- Department of Internal Medicine, Ankara Numune Training and Research Hospital
| |
Collapse
|
26
|
Katipoglu B, Ates I, Demir BF, Yirgin G, Yilmaz N, Dede F. Relationship Between Monocyte/HDL Cholesterol Ratio and Urinary Protein Excretion in Patients with Primary Hypertension with Reverse Dipper Pattern. Turk J Nephrol 2019. [DOI: 10.5152/turkjnephrol.2019.3203] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
27
|
Yalın SF, Eren N, Sinangil A, Yilmaz VT, Tatar E, Ucar AR, Sevinc M, Can Ö, Gurkan A, Arik N, Alisir Ecder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, Köksal Cevher Ş, Turkmen K, Guven B, Guven Taymez D, Erkalma Senates B, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, Bicik Bahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altıparmak MR, Turkmen A, Seyahi N. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey. Nephron Clin Pract 2019; 142:26-33. [PMID: 30739116 DOI: 10.1159/000496620] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2018] [Accepted: 12/22/2018] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from lack of alpha-galactosidase A (AGALA) activity in lysosomes. OBJECTIVE In this multicenter study, we aimed to evaluate the prevalence of FD in renal transplant (Tx) recipients in Turkey. We also screened dialysis patients as a control group. METHODS All Tx and dialysis patients were screened regardless of the presence of a primary disease. We measured the AGALA activity in all male patients as initial analysis. Mutation analysis was performed in male patients with decreased AGALA activity and in female patients as the initial diagnostic assay. RESULTS We screened 5,657 patients. A total of 17 mutations were identified. No significant difference was observed between the groups regarding the prevalence of patients with mutation. We found FD even in patients with presumed primary kidney diseases. Seventy-one relatives were analyzed and mutation was detected in 43 of them. We detected a patient with a new, unknown mutation (p.Cys223) in the GLA gene. CONCLUSIONS There are important implications of the screening. First, detection of the undiagnosed patients leads to starting appropriate therapies for these patients. Second, the transmission of the disease to future generations may be prevented by prenatal screening after appropriate genetic counseling. In conclusion, we suggest screening of kidney Tx candidates for FD, regardless of etiologies of chronic kidney disease.
Collapse
Affiliation(s)
- Serkan Feyyaz Yalın
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Necmi Eren
- Department of Nephrology, Kocaeli University Medical Faculty, Kocaeli, Turkey
| | - Ayse Sinangil
- Department of Nephrology, Bilim University Medical Faculty Medical, Istanbul, Turkey
| | - Vural Taner Yilmaz
- Division of Nephrology, Akdeniz University Medical Faculty, Antalya, Turkey
| | - Erhan Tatar
- Department of Nephrology, Bozyaka Training and Research Hospital, Izmir, Turkey
| | - Ali Riza Ucar
- Division of Nephrology, Istanbul University, Faculty of Medicine, Istanbul, Turkey
| | - Mustafa Sevinc
- Department of Nephrology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | - Özgür Can
- Department of Nephrology, Haydarpasa Training and Research Hospital, Istanbul, Turkey
| | - Alp Gurkan
- Department of Nephrology, Medicana, Istanbul, Turkey
| | - Nurol Arik
- Department of Nephrology, Ondokuz Mayis University Medical Faculty, Samsun, Turkey
| | - Sabahat Alisir Ecder
- Division of Nephrology, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Murathan Uyar
- Department of Nephrology, Gaziosmanpasa Hospital, Istanbul, Turkey
| | - Murat Yasar
- Department of Nephrology, Pamukkale University Medical Faculty, Denizli, Turkey
| | - Sibel Gulcicek
- Department of Nephrology, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Meral Mese
- Department of Nephrology, Dr. Lufti Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Hamad Dheir
- Department of Nephrology, Sakarya University Tip Medical Faculty, Sakarya, Turkey
| | - Ulkem Cakir
- Department of Nephrology, Acibadem University Medical Faculty, Istanbul, Turkey
| | - Şimal Köksal Cevher
- Department of Nephrology, Ankara Training and Research Hospital, Ankara, Turkey
| | - Kultigin Turkmen
- Division of Nephrology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey
| | - Bahtisen Guven
- Department of Nephrology, Bahcesehir University Medical Faculty, Istanbul, Turkey
| | | | - Banu Erkalma Senates
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Tevfik Ecder
- Department of Nephrology, Bilim University Medical Faculty Medical, Istanbul, Turkey
| | - Huseyin Kocak
- Division of Nephrology, Akdeniz University Medical Faculty, Antalya, Turkey
| | - Adam Uslu
- Department of Nephrology, Bozyaka Training and Research Hospital, Izmir, Turkey
| | - Erol Demir
- Division of Nephrology, Istanbul University, Faculty of Medicine, Istanbul, Turkey
| | - Taner Basturk
- Department of Nephrology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | - Melike Betul Ogutmen
- Department of Nephrology, Haydarpasa Training and Research Hospital, Istanbul, Turkey
| | - Can Kinalp
- Department of Nephrology, Medicana, Istanbul, Turkey
| | - Belda Dursun
- Department of Nephrology, Pamukkale University Medical Faculty, Denizli, Turkey
| | - Zerrin Bicik Bahcebasi
- Department of Nephrology, Dr. Lufti Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Savas Sipahi
- Department of Nephrology, Sakarya University Tip Medical Faculty, Sakarya, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara Training and Research Hospital, Ankara, Turkey
| | - Meric Oruc
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Yasar Caliskan
- Division of Nephrology, Istanbul University, Faculty of Medicine, Istanbul, Turkey
| | - Ahmed Genc
- Department of Nephrology, Sakarya University Tip Medical Faculty, Sakarya, Turkey
| | - Berna Yelken
- Department of Nephrology, Memorial Hospital, Istanbul, Turkey
| | - Mehmet Rıza Altıparmak
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Aydin Turkmen
- Division of Nephrology, Istanbul University, Faculty of Medicine, Istanbul, Turkey
| | - Nurhan Seyahi
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey,
| |
Collapse
|
28
|
Gürbüz HGA, Turhan L, Şendil N, Kaşıkçı HÖ, Salepçi B, Ipekcioglu D, Karcı CK, Ray PÇ, Tahiroğlu AY, Avcı A, Çelik GG, Cekin N, Evliyaoğlu N, Alkanat M, Özdemir H, Akgün E, Demirkol ME, Tamam L, Esnafoglu E, Sevinçok D, Memiş ÇÖ, Doğan B, Çakaloz B, Kutlu A, Sevinçok L, Demirkol ME, Dikmen SNT, Şafak Y, Gökçer Tulacı R, Özdemir İ, Baykara S, Alban K, Aydın N, Aytaç HM, Yılmaz D, Aydın PÇ, Yalçın GY, Canbay C, Terzioğlu M, Özer A, Altintas E, Kütük MÖ, Tufan AE, Bağ HG, Şenormancı G, Güçlü O, Çelik C, Bolu A, Öznur T, Aydın MS, Tokgöz Y, Uzun Ö, Gıca S, Poyraz BÇ, Fidan YS, Güleç H, Akça E, Yıldız M, Akça ZND, Öztürk Y, Özyurt G, Özdel K, Özyurt G, Öztürk Y, Özdel K, Elboga G, Ozyurek MB, Bolu A, Aydın MS, Akgün A, Coşkun A, Çelik C, Uzun Ö, Öznur T, Bilgiç A, Sivri RÇ, Kılınç İ, İnal A, Eray U, Memiş ÇÖ, Doğan B, Acat M, Sevinçok L, Önder A, Adanır AS, Kavurma C, Bilaç Ö, Doğan Y, Ay R, Uğur Ç, Alıç BG, Gündüz M, Ünal Ö, Uçur Ö, Özcan Ö, Gül HK, Aykut DS, Tiryaki A, Arslan FC, Adanır AS, Önder A, Bülbül GA, Yolcu Ö, Uysal A, Özatalay E, Esnafoglu E, Cırrık S, Erdogan E, Delibas DH, Bozkurt HT, Tekdemir R, Erbasan V, İmre O, Aydın M, Altınbaş K, Karabucak B, Esen HTÇ, Kültür SEÇ, Karaokur R, Uysal SA, Erbil N, Kirazlı MÇ, Kara T, Mıhçıoğlu AM, Yılmaz S, Akaltun İ, Atli A, Can Z, Çim EFA, İbiloğlu AO, Şahin N, Ertekin H, Kocagöz ZB, Özçetin A, Ataoğlu A, Cangür Ş, Ölmez SB, Yazar N, Uçar HN, Murat D, Eray Ş, Tanır Y, Altun H, Tanyeri MH, Büyükokuroğlu ME, Tanyeri P, Mutlu O, Akar FY, Ulak G, Erden BF, Sevgen FH, Altun H, Arıcı A, Kılıçaslan F, Erbay MF, Darılmaz C, Çökmüş FP, Yüzeren S, Dikici DS, Aydın O, Aydın PÜ, Akdeniz F, Öztekin S, Çöldür EÖ, Balıkçı K, Köroğlu E, Aydemir Ö, Kara H, Özçelik Ö, Balcı MM, Kuloğlu MM, Tomar T, Öztekin S, Akdeniz F, Taneli F, Oran A, Ovalı GY, Aydemir Ö, Kaypaklı GY, Metin Ö, Ray PÇ, Çelik GG, Karcı CK, Tahiroğlu AY, Karaş H, Çetingök H, İlişer R, Çarpar E, Kaşer M, Can GŞ, Ulaş G, Ildız A, Emiroğlu N, Ada E, Özerdem A, Tekdemir R, Bozkurt HT, Imre O, Erbasan V, Aydın M, Altınbaş K, Tanyeri MH, Büyükokuroğlu ME, Tanyeri P, Mutlu O, Akar FY, Ulak G, Erden BF, Tekin U, Satar A, Aydın AN, Erermiş HS, Kocaman O, Çetin NY, Akay A, Karagöz YS, Doğan Ö, Ülkar S, Kılıç BG, Ceyhun HA, Aydın EF, Ülkevan T, Gürbüzer N, Aykutlu HC, Görker I, Özen E, Aktepe E, Aydın MA, Yavuz DD, Karaaslan U, Altun H, Karataş A, Sancak Z, Çetin NY, Dikici DS, Çökmüş FP, Eser E, Demet MM, Karadere ME, Asafov EY, Ölçüm Hİ, Algül A, Gündoğmuş İ, Cetin FH, Guler HA, Turkoglu S, Çolpan BK, Tanır Y, Bayram E, Ateş FSÖ, Teber ST, Kılıç BG, Duman NS, Gökten ES, Sungur EN, Şengül MCB, Kardeşler AÇ, Enli Y, Kurtul N, Altun H, Aslan C, Konuşkan B, Şener B, Anlar B, Ünal F, Akçay BD, Koç G, Yetkin S, Bayad S, Elbir M, Topbaş ÖA, Kocabaş T, Aydemir Ö, Çim EFA, Aydın A, Atli A, Atli A, Avcu Çelik P, İbiloğlu AO, Çıldır DA, Özbek A, Mustan AT, Karadağ AS, Kalenderoğlu A, Örüm MH, Özen ME, Eğilmez OB, Kalenderoğlu A, Karadağ AS, Hamdi Örüm M, Özen ME, Aydın DB, Elmas B, Nasıroğlu S, Aydın E, Özdemir Ö, Erel Ö, Altun H, Fedai Ü, Asoğlu M, Elbay RY, Karatepe HT, Ulaşoğlu C, Ayaydın H, Kılıçaslan F, Asoğlu M, Şahin B, Karabekiroğlu K, Bozkurt A, Usta MB, Aydın M, Çobanoğlu C, Kara H, Kahya Y, Özçelik Ö, İnan D, Kuloğlu MM, Altınöz AE, Köşger F, Eşsizoğlu A, Arslan M, Çalışkan AM, Göktaş D, İnanlı İ, Çalışır S, Eren İ, Tatar ZB, Kurt E, Unal G, Aricioglu F, Cetin FH, Guler HA, Tezcan ME, Turkoglu S, Kalyoncu T, Çıldır DA, Ergüvendi F, Yektaş Ç, Eroz R, Yurdakul G, Cakır M, Tasmektepligil MY, Baykal S, Usta MB, Karakurt MN, Karabekiroglu K, Yulaf Y, Gümştaş F, Gökçe S, Yazgan Y, Memiş ÇÖ, Sevincok D, Doğan B, Kutlu A, Çakaloz B, Sevinçok L, Çıldır DA, Kalyoncu T, Ergüvendi FA, Uğur Ç, Yağcı İ, Avcı S, Kıvrak Y, Yaşar AB, Sayman C, Taycan SE, Çetinkaya Y, Gündüz A, Tireli H, Yazici KU, Yazici IP, Kıvrak Y, Kılıçle PA, Gül S, Yağcı İ, Yazici IP, Yazici KU, Çıldır DA, Özbek A, Sümer AD, Çöp E, Bilgili D, Şahin M, Dinç GŞ, Hekim Ö, Mısırlıoğlu ED, Kurt F, Göker Z, Üneri Ö, Kıvrak Y, Kıvrak Y, Yağcı İ, Kıvrak Y, Atalay E, Yıldırım İ, Yağcı İ, İnaltekin A, Yücens B, Kotan VO, Özkayar N, Dede F, Yüksel RN, Bayram Ş, Kotan Z, Göka E, Bozkurt A, Say GN, Şahin B, Usta MB, Kalyoncu M, Aydın M, Çobanoğlu C, Beğinoğlu Ö, Asoğlu M, Basgoz BB, Ince S, Safer U, Tasci İ. Oral Research Presentations. PSYCHIAT CLIN PSYCH 2018. [DOI: 10.1080/24750573.2018.1464273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Affiliation(s)
| | - Levent Turhan
- Kartal Dr. Lutfi Kirdar Research and Training Hospital, Istanbul, Turkey
| | - Nilgun Şendil
- Kartal Suleyman Demirel Anatolian High School, Istanbul, Turkey
| | | | | | - Derya Ipekcioglu
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Canan Kuygun Karcı
- Dr. Ekrem Tok Psychiatry Hospital, Department of Child and Adolescent Psychiatry, Adana, Turkey
| | - Perihan Çam Ray
- Cukurova University School of Medicine, Department of Child and Adolescent Psychiatry, Adana, Turkey
| | - Ayşegül Yolga Tahiroğlu
- Cukurova University School of Medicine, Department of Child and Adolescent Psychiatry, Adana, Turkey
| | - Ayşe Avcı
- Cukurova University School of Medicine, Department of Child and Adolescent Psychiatry, Adana, Turkey
| | - Gonca Gül Çelik
- Cukurova University School of Medicine, Department of Child and Adolescent Psychiatry, Adana, Turkey
| | - Necmi Cekin
- Cukurova University School of Medicine, Department of forensic Medicine, Adana, Turkey
| | - Nurdan Evliyaoğlu
- Cukurova University School of Medicine, Department of Pediatrics, Adana, Turkey
| | - Mehmet Alkanat
- Departmant of Physiology, Giresun University School of Medicine, Giresun, Turkey
| | - Hafize Özdemir
- Departmant of Internal Medicine Nursing, School of Health Sciences, Giresun University, Giresun, Turkey
| | - Egemen Akgün
- Departmant of Medical Biology, Giresun University School of Medicine, Giresun, Turkey
| | | | - Lut Tamam
- Cukurova University School of Medicine, Department of Psychiatry, Adana
| | | | - Doğa Sevinçok
- Dr. Behcet Uz Child Diseases and Pediatric Surgery Training and Research Hospital, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | | | - Bilge Doğan
- Adnan Menderes University, Department of Psychiatry, Aydin, Turkey
| | - Burcu Çakaloz
- Pamukkale University, Department of Child and Adolescent Psychiatry, Denizli, Turkey
| | - Ayşe Kutlu
- Dr. Behcet Uz Child Diseases and Pediatric Surgery Training and Research Hospital, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Levent Sevinçok
- Adnan Menderes University, Department of Psychiatry, Aydin, Turkey
| | | | | | - Yasir Şafak
- Dışkapı Yıldırım Beyazıt Education and Training Hospital, Ankara, Turkey
| | | | - İlker Özdemir
- Kütahya Dr. Mustafa Kalemli Tavşanlı Government Hospital, Kütahya, Turkey
| | - Sema Baykara
- Firat University, School of Medicine, Department of Psychiatry, Elazig, Turkey
| | - Kübra Alban
- Elazig Mental Health Hospital, Elazig, Turkey
| | - Nazan Aydın
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Hasan Mervan Aytaç
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Doğan Yılmaz
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Pınar Çetinay Aydın
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Gökşen Yüksel Yalçın
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Cana Canbay
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Merve Terzioğlu
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Aysel Özer
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Ebru Altintas
- Baskent University School of Medicine, Department of Psychiatry, Adana, Turkey
| | - Meryem Özlem Kütük
- Baskent University School of Medicine, Department of Child and adolescent Psychiatry, Adana, Turkey
| | - Ali Evren Tufan
- Abant İzzet Baysal University, School of Medicine, Department of Child and adolescent Psychiatry, Bolu, Turkey
| | - Harika Gözükara Bağ
- Inonu University, Department of Biostatistics and Medical Informatics, Malatya, Turkey
| | - Güliz Şenormancı
- Health Sciences University Bursa Yüksek İhtisas Training and Research Hospital, Department of Psychiatry, Bursa, Turkey
| | - Oya Güçlü
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Cemil Çelik
- Gulhane Medical Faculty, Department of Psychiatry, Ankara, Turkey
| | - Abdullah Bolu
- Gulhane Medical Faculty, Department of Psychiatry, Ankara, Turkey
| | - Taner Öznur
- Gulhane Medical Faculty, Department of Psychiatry, Ankara, Turkey
| | | | - Yusuf Tokgöz
- Gulhane Medical Faculty, Department of Psychiatry, Ankara, Turkey
| | - Özcan Uzun
- Gulhane Medical Faculty, Department of Psychiatry, Ankara, Turkey
| | - Sakır Gıca
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Burç Çağrı Poyraz
- Istanbul University Cerrahpasa School of Medicine, Department of Psychiatry, Istanbul, Turkey
| | - Yağmur Sever Fidan
- Erenkoy Research and Training Hospital for Psychiatric and Neurological Disorders, Department of Psychiatry, Istanbul, Turkey
| | - Hüseyin Güleç
- Erenkoy Research and Training Hospital for Psychiatric and Neurological Disorders, Department of Psychiatry, Istanbul, Turkey
| | - Erdoğdu Akça
- Psychiatry, Marmara University School of Medicine, İstanbul, Turkey
| | - Mesut Yıldız
- Psychiatry, Marmara University School of Medicine, İstanbul, Turkey
| | | | - Yusuf Öztürk
- Abant Izzet Baysal University, Department of Child and Adolescent Psychiatry, Bolu, Turkey
| | - Gonca Özyurt
- İzmir Katip Celebi University, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Kadir Özdel
- Dıskapi Training and Research Hospital, Department of Psychiatry, Ankara, Turkey
| | - Gonca Özyurt
- İzmir Katip Celebi University, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Yusuf Öztürk
- Abant Izzet Baysal University, Department of Child and Adolescent Psychiatry, Bolu, Turkey
| | - Kadir Özdel
- Dıskapi Training and Research Hospital, Department of Psychiatry, Ankara, Turkey
| | - Gulcin Elboga
- Gaziantep University School of Medicine Department of Psychiatry
| | | | - Abdullah Bolu
- Gülhane Medical School; Dept. of Psychiatry. Ankara/Turkey
| | | | - Abdullah Akgün
- Gülhane Medical School; Dept. of Psychiatry. Ankara/Turkey
| | - Ali Coşkun
- Gülhane Medical School; Dept. of Pathology. Ankara/Turkey
| | - Cemil Çelik
- Gülhane Medical School; Dept. of Psychiatry. Ankara/Turkey
| | - Özcan Uzun
- Gülhane Medical School; Dept. of Psychiatry. Ankara/Turkey
| | - Taner Öznur
- Gülhane Medical School; Dept. of Psychiatry. Ankara/Turkey
| | - Ayhan Bilgiç
- Department of Child and Adolescent Psychiatry, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey
| | - Rukiye Çolak Sivri
- Department of Child and Adolescent Psychiatry, Ankara Education and Research Hospital, Ankara, Turkey
| | - İbrahim Kılınç
- Department of Biochemistry, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey
| | - Ahmet İnal
- Erciyes University School of Medicine, Department of Pharmacology, Hakan Çetinsaya Good Clinical Practice and Research Center, Kayseri, Turkey
| | - Uğur Eray
- Adnan Menderes University School of Medicine, Department of Psychiatry, Aydın, Turkey
| | - Çağdaş Öykü Memiş
- Adnan Menderes University School of Medicine, Department of Psychiatry, Aydın, Turkey
| | - Bilge Doğan
- Adnan Menderes University School of Medicine, Department of Psychiatry, Aydın, Turkey
| | - Murat Acat
- Karabük University School of Medicine, Department of Pulmonary Diseases, Karabük, Turkey
| | - Levent Sevinçok
- Adnan Menderes University School of Medicine, Department of Psychiatry, Aydın, Turkey
| | - Arif Önder
- Manisa Mental Health Hospital, Department of Child and Adolescent Psychiatry, Manisa, Turkey
| | - Aslı Sürer Adanır
- Akdeniz University School of Medicine, Department of Child and Adolescent Psychiatry, Antalya, Turkey
| | - Canem Kavurma
- Manisa Mental Health Hospital, Department of Child and Adolescent Psychiatry, Manisa, Turkey
| | - Öznur Bilaç
- Manisa Mental Health Hospital, Department of Child and Adolescent Psychiatry, Manisa, Turkey
| | - Yakup Doğan
- Manisa Mental Health Hospital, Department of Child and Adolescent Psychiatry, Manisa, Turkey
| | - Rukiye Ay
- Malatya Training and Research Hospital
| | - Çağatay Uğur
- Health Sciences University, Ankara Child Health and Diseases Hematology Oncology Research and Training Hospital, Child and Adolescent Psychiatry Department, Ankara, Turkey
| | - Betül Gül Alıç
- Health Sciences University, Ankara Child Health and Diseases Hematology Oncology Research and Training Hospital, Child and Adolescent Psychiatry Department, Ankara, Turkey
| | - Mehmet Gündüz
- Health Sciences University, Ankara Child Health and Diseases Hematology Oncology Research and Training Hospital, Department of Child Metabolism and Nutrition, Ankara, Turkey
| | - Özlem Ünal
- Health Sciences University, Ankara Child Health and Diseases Hematology Oncology Research and Training Hospital, Department of Child Metabolism and Nutrition, Ankara, Turkey
| | - Ömer Uçur
- Inonu University School of Medicine, Department of Child and Adolescent Psychiatry, Malatya, Turkey
| | - Özlem Özcan
- Inonu University School of Medicine, Department of Child and Adolescent Psychiatry, Malatya, Turkey
| | - Hasret Karabulut Gül
- Karadeniz Technical University School of Medicine, Department of Psychiatry, Trabzon, Turkey
| | - Demet Sağlam Aykut
- Karadeniz Technical University School of Medicine, Department of Psychiatry, Trabzon, Turkey
| | - Ahmet Tiryaki
- Istanbul Aydın University School of Medicine, Department of Psychiatry, Istanbul, Turkey
| | - Filiz Civil Arslan
- Karadeniz Technical University School of Medicine, Department of Psychiatry, Trabzon, Turkey
| | - Aslı Sürer Adanır
- Akdeniz University School of Medicine, Department of Child and Adolescent Psychiatry, Antalya, Turkey
| | - Arif Önder
- Manisa Psychiatry Hospital, Department of Child and Adolescent Psychiatry, Manisa, Turkey
| | - Gül Alkan Bülbül
- Antalya Training and Research Hospital, Department of Gynecology and Obstetrics, Antalya, Turkey
| | - Ömer Yolcu
- Akdeniz University School of Medicine, Department of Child and Adolescent Psychiatry, Antalya, Turkey
| | - Aysel Uysal
- Antalya Training and Research Hospital, Department of Gynecology and Obstetrics, Antalya, Turkey
| | - Esin Özatalay
- Akdeniz University School of Medicine, Department of Child and Adolescent Psychiatry, Antalya, Turkey
| | - Erman Esnafoglu
- Department of Child and Adolescent Psychiatry, School of Medicine, Ordu University, Ordu, Turkey
| | - Selma Cırrık
- Department of Physiology, School of Medicine, Ordu University, Ordu, Turkey
| | - Esin Erdogan
- University of Health Sciences, Izmir Bozyaka Research and Training Hospital, Department of Psychiatry, Izmir
| | - Dursun Hakan Delibas
- University of Health Sciences, Izmir Bozyaka Research and Training Hospital, Department of Psychiatry, Izmir
| | - Hazan Tomar Bozkurt
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Rukiye Tekdemir
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Vefa Erbasan
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Okan İmre
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Memduha Aydın
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Kürşat Altınbaş
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Başak Karabucak
- Department of Child and Adolescent Psychiatry, Karaman State Hospital, Karaman, Turkey
| | - Halime Tuna Çak Esen
- Department of Child and Adolescent Psychiatry, Hacettepe University, Ankara, Turkey
| | | | - Remzi Karaokur
- Department of Child and Adolescent Psychiatry, Sincan State Hospital, Ankara, Turkey
| | - Songül Atasavun Uysal
- Department of Physical Therapy and Rehabilitation, Institute of Health Sciences, Hacettepe University, Ankara, Turkey
| | - Nurhan Erbil
- Department of Biophysics, Hacettepe University, Ankara, Turkey
| | | | - Tayfun Kara
- University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Child and Adolescent Psychiatry, Istanbul, Turkey
| | - Ajda Mutlu Mıhçıoğlu
- Health Sciences University, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Pediatric Cardiology, Istanbul, Turkey
| | - Semra Yılmaz
- University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Child and Adolescent Psychiatry, Istanbul, Turkey
| | - İsmail Akaltun
- Gaziantep Dr. Ersin Arslan Training and Research Hospital, Department of Child and Adolescent Psychiatry Gaziantep, Turkey
| | - Abdullah Atli
- Dicle University School of Medicine, Department of Psychiatry, Diyarbakir, Turkey
| | - Zübeyir Can
- Batman Regional State Hospital, Batman, Turkey
| | | | | | - Nilfer Şahin
- Muğla Sıtkı Koçman University School of Medicine, Department of Child and Adolescent Psychiatry, Muğla, Turkey
| | - Hülya Ertekin
- Çanakkale 18 Mart University, School of Medicine, Çanakkale, Turkey
| | | | - Adnan Özçetin
- Duzce University School of Medicine, Department of Psychiatry, Duzce Turkey
| | - Ahmet Ataoğlu
- Duzce University School of Medicine, Department of Psychiatry, Duzce Turkey
| | - Şengül Cangür
- Duzce University School of Medicine, Department of Psychiatry, Duzce Turkey
| | - Safiye Bahar Ölmez
- Duzce University School of Medicine, Department of Psychiatry, Duzce Turkey
| | - Neslihan Yazar
- Duzce University School of Medicine, Department of Psychiatry, Duzce Turkey
| | - Halit Necmi Uçar
- Department of Child and Adolescent Psychiatry, Van Training and Research Hospital, Van, Turkey
| | - Duygu Murat
- Department of Child and Adolescent Psychiatry, Avcılar Hospital, İstanbul, Turkey
| | - Şafak Eray
- Department of Child and Adolescent Psychiatry, Van Training and Research Hospital, Van, Turkey
| | - Yaşar Tanır
- Department of Child and Adolescent Psychiatry, Kutahya Dumlupınar University Evliya Celebi Training and Research Hospital, Kütahya, Turkey
| | - Hatice Altun
- Department of Child and Adolescent Psychiatry, Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | | | | | - Pelin Tanyeri
- Sakarya University School of Medicine, Department of Pharmacology, Sakarya, Turkey
| | - Oguz Mutlu
- Kocaeli University School of Medicine, Department of Pharmacology, Kocaeli, Turkey
| | - Füruzan Yıldız Akar
- Kocaeli University School of Medicine, Department of Pharmacology, Kocaeli, Turkey
| | - Güner Ulak
- Kocaeli University School of Medicine, Department of Pharmacology, Kocaeli, Turkey
| | - Bekir Faruk Erden
- Kocaeli University School of Medicine, Department of Pharmacology, Kocaeli, Turkey
| | - Feyza Hatice Sevgen
- Department of Child and Adolescent Psychiatry, Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Hatice Altun
- Department of Child and Adolescent Psychiatry, Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Asiye Arıcı
- Department of Child and Adolescent Psychiatry, Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Fethiye Kılıçaslan
- Department of Child and Adolescent Psychiatry, Harran University School of Medicine, Sanlıurfa, Turkey
| | - Mehmet Fatih Erbay
- Inonu University School of Medicine, Department of Radiology, Malatya, Turkey
| | - Cengiz Darılmaz
- Inonu University School of Medicine, Department of Psychiatry, Malatya, Turkey
| | | | - Serra Yüzeren
- Departmant of Psychiatry, Manisa Celal Bayar University, Manisa, Turkey
| | | | - Orkun Aydın
- Department of Psychology, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina
| | - Pınar Ünal Aydın
- Department of Psychology, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina
| | - Fatma Akdeniz
- Psychiatry Clinic, Bolvadin Halil İbrahim Özsoy State Hospital, Afyon, Turkey
| | - Siğnem Öztekin
- Psychiatry Clinic, Viranşehir State Hospital, Şanlıurfa, Turkey
| | - Emine Özge Çöldür
- Departmant of Psychiatry, Manisa Celal Bayar University, Manisa, Turkey
| | - Kuzeymen Balıkçı
- Department of Psychiatry, Near East University, Lefkoşa, North Cyprus
| | | | - Ömer Aydemir
- Departmant of Psychiatry, Manisa Celal Bayar University, Manisa, Turkey
| | - Hüseyin Kara
- Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey
| | - Özgen Özçelik
- Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey
| | - Mehmet Murat Balcı
- Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey
| | - Mehmet Murat Kuloğlu
- Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey
| | - Talya Tomar
- Medical School, Akdeniz University School of Medicine, Antalya, Turkey
| | - Siğnem Öztekin
- Viransehir State Hospital, Department of Psychiatry, Viransehir, Sanliurfa, Turkey
| | - Fatma Akdeniz
- Bolvadin Halil Ibrahim Ozsoy State Hospital, Department of Psychiatry, Bolvadin, Afyonkarahisar, Turkey
| | - Fatma Taneli
- Celal Bayar University School of Medicine, Department of Biochemistry, Manisa, Turkey
| | - Arzu Oran
- Manisa State Hospital, Department of Biochemistry, Manisa, Turkey
| | - Gülgün Yılmaz Ovalı
- Celal Bayar University School of Medicine, Department of Radiology, Manisa, Turkey
| | - Ömer Aydemir
- Celal Bayar University School of Medicine, Department of Psychiatry, Manisa, Turkey
| | - Gamze Yapça Kaypaklı
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Özge Metin
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Perihan Çam Ray
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Gonca Gül Çelik
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Canan Kuygun Karcı
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Ayşegül Yolga Tahiroğlu
- Cukurova University School of Medicine, Child and Adolescent Psychiatry Department, Adana, Turkey
| | - Hakan Karaş
- Beykent University, Department of Psychology, Istanbul, Turkey
| | - Halil Çetingök
- Bağcılar Education and Research Hospital, Department of Anesthesiology and Reanimation, Istanbul, Turkey
| | - Reşat İlişer
- Genesis Hospital, Department of Physical Therapy and Rehabilitation, Diyarbakır, Turkey
| | - Elif Çarpar
- Hınıs State Hospital, Department of Psychiatry, Erzurum, Turkey
| | - Muzaffer Kaşer
- University of Cambridge, Department of Psychiatry, Cambridge, UK; Bahçeşehir University, Department of Psychiatry, Istanbul, Turkey
| | - Güneş Şayan Can
- Mardin State Hospital, Department of Psychiatry, Mardin, Turkey
| | - Gözde Ulaş
- Dokuz Eylul University School of Medicine, Child and Adult Psychiatry, Izmır, Turkey
| | - Ayşegül Ildız
- Dokuz Eylul University Health Sciences Institute, Neuroscience, Izmır, Turkey
| | - Neslihan Emiroğlu
- Dokuz Eylul University School of Medicine, Child and Adult Psychiatry, Izmır, Turkey
| | - Emel Ada
- Dokuz Eylül University School of Medicine, Department of Radiology, Izmır, Turkey
| | - Ayşegül Özerdem
- Dokuz Eylul University School of Medicine, Department of Psychiatry, Izmir, Turkey
| | - Rukiye Tekdemir
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Hazan Tomar Bozkurt
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Okan Imre
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Vefa Erbasan
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Memduha Aydın
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | - Kürşat Altınbaş
- Selcuk University School of Medicine, Department of Psychiatry, Konya, Turkey
| | | | | | - Pelin Tanyeri
- Sakarya University, School of Medicine, Department of Pharmacology, 54100-Sakarya/Turkey
| | - Oğuz Mutlu
- Kocaeli University, School of Medicine, Department of Pharmacology, 41380-Kocaeli/Turkey
| | - Furuzan Yıldız Akar
- Kocaeli University, School of Medicine, Department of Pharmacology, 41380-Kocaeli/Turkey
| | - Güner Ulak
- Kocaeli University, School of Medicine, Department of Pharmacology, 41380-Kocaeli/Turkey
| | - Bekir Faruk Erden
- Kocaeli University, School of Medicine, Department of Pharmacology, 41380-Kocaeli/Turkey
| | - Uğur Tekin
- Health Sciences University Van Research and Training Hospital, Van, Turkey
| | - Ayşegül Satar
- Ege University School of Medicine, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Ayşe Nur Aydın
- Ege University School of Medicine, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Hatice Serpil Erermiş
- Ege University School of Medicine, Department of Child and Adolescent Psychiatry, Izmir, Turkey
| | - Orhan Kocaman
- TR Ministry of Health, DPU Kütahya Evliya Çelebi Research and Training Hospital, Kütahya, Turkey
| | - Nihal Yurteri Çetin
- Düzce University School of Medicine, Child and Adolescent Psychiatry, Düzce, Turkey
| | - Aynur Akay
- Dokuz Eylül University School of Medicine, Child and Adolescent Psychiatry, İzmir, Turkey
| | - Yüksel Sümeyra Karagöz
- Child and Adolescent Psychiatry Department, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey
| | - Özlem Doğan
- Department of Biochemistry, Ankara University School of Medicine, Ankara, Turkey
| | - Serenay Ülkar
- Department of Biochemistry, Ankara University School of Medicine, Ankara, Turkey
| | - Birim Günay Kılıç
- Child and Adolescent Psychiatry Department, Ankara University School of Medicine, Ankara, Turkey
| | - Hacer Akgül Ceyhun
- Department of Psychiatry, Ataturk University School of Medicine, Erzurum, Turkey
| | - Esat Fahri Aydın
- Department of Psychiatry, Ataturk University School of Medicine, Erzurum, Turkey
| | - Tuba Ülkevan
- Department of Psychiatry, Health Scıence Unıversity Van Training and Research Hospital, Van, Turkey
| | - Nilifer Gürbüzer
- Department of Psychiatry, Ataturk University School of Medicine, Erzurum, Turkey
| | - Hasan Cem Aykutlu
- Trakya University School of Medicine, Child and Adolescent Psychiatry Department, Edirne, Turkey
| | - Işık Görker
- Trakya University School of Medicine, Child and Adolescent Psychiatry Department, Edirne, Turkey
| | - Emel Özen
- Department of Child and Adolescent Psychiatry, Suleyman Demirel University School of Medicine, Isparta, Turkey
| | - Evrim Aktepe
- Department of Child and Adolescent Psychiatry, Suleyman Demirel University School of Medicine, Isparta, Turkey
| | - Mustafa Asım Aydın
- Department of Plastic and Reconstructive Surgery, Suleyman Demirel University School of Medicine, Isparta, Turkey
| | - Dudu Dilek Yavuz
- Department of Plastic and Reconstructive Surgery, Suleyman Demirel University School of Medicine, Isparta, Turkey
| | - Umut Karaaslan
- Department of Child and Adolescent Psychiatry, Sütçü İmam University School of Medicine, Kahramanmaraş, Turkey
| | - Hatice Altun
- Department of Child and Adolescent Psychiatry, Sütçü İmam University School of Medicine, Kahramanmaraş, Turkey
| | - Abdullah Karataş
- Department of Child and Adolescent Psychiatry, Sütçü İmam University School of Medicine, Kahramanmaraş, Turkey
| | - Zehra Sancak
- İstanbul Gelişim University, Clinical Psychology, Istanbul, Turkey
| | - Nihal Yurteri Çetin
- Düzce University School of Medicine, Child and Adolescent Psychiatry, Düzce, Turkey
| | | | | | - Erhan Eser
- Department of Public Health, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | - Mehmet Murat Demet
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | | | - Ece Yazla Asafov
- Hitit University, School of Medicine Department of Psychiatry, Çorum, Turkey
| | | | - Ayhan Algül
- Sultan Abdulhamid Han Research and Training Hospital, Department of Psychiatry, Istanbul
| | - İbrahim Gündoğmuş
- Sultan Abdulhamid Han Research and Training Hospital, Department of Psychiatry, Istanbul
| | - Fatih Hilmi Cetin
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Hasan Ali Guler
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Serhat Turkoglu
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Bahar Keleş Çolpan
- Department of Otolaryngology, Selçuk University School of Medicine, Konya, Turkey
| | - Yaşar Tanır
- Department of Child and Adolescent Psychiatry, Kutahya Dumlupınar University Evliya Celebi Training and Research Hospital, Kütahya, Turkey
| | - Elif Bayram
- Department of Child and Adolescent Psychiatry, Ankara University School of Medicine, Ankara Turkey
| | | | - Serap Tıraş Teber
- Department of Pediatric Neurology, Ankara University School of Medicine, Ankara, Turkey
| | - Birim Günay Kılıç
- Department of Child and Adolescent Psychiatry, Ankara University School of Medicine, Ankara Turkey
| | - Nagihan Saday Duman
- Department of Child and Adolescent Psychiatry, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey
| | - Emel Sarı Gökten
- Department of Child and Adolescent Psychiatry, NPIstanbul Brain Hospital of Uskudar University, İstanbul, Turkey
| | | | | | - Ayşen Çetin Kardeşler
- Department of Biochemistry, Pamukkale University School of Medicine, Denizli, Turkey
| | - Yaşar Enli
- Department of Biochemistry, Pamukkale University School of Medicine, Denizli, Turkey
| | - Neslihan Kurtul
- Department of Radiation Oncology, Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Hatice Altun
- Department of Child and Adolescent Psychiatry, Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Cihan Aslan
- Kırıkkale Yüksek İhtisas State Hospital, Department of Child and Adolescent Psychiatry, Kırıkkale, Turkey
| | - Bahadır Konuşkan
- Hacettepe University School of Medicine, Department of Pediatric Neurology, Ankara, Turkey
| | - Burçin Şener
- Hacettepe University School of Medicine, Department of Medical Microbiology, Ankara, Turkey
| | - Banu Anlar
- Hacettepe University School of Medicine, Department of Pediatric Neurology, Ankara, Turkey
| | - Fatih Ünal
- Hacettepe University School of Medicine, Department of Child and Adolescent Psychiatry, Ankara, Turkey
| | - Bülent Devrim Akçay
- Gülhane Research and Training Hospital, Psychiatry Clinic, Sleep Research Center, Ankara, Turkey
| | - Güray Koç
- Gülhane Research and Training Hospital, Psychiatry Clinic, Sleep Research Center, Ankara, Turkey
| | - Sinan Yetkin
- Gülhane Research and Training Hospital, Psychiatry Clinic, Sleep Research Center, Ankara, Turkey
| | - Serkan Bayad
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | - Müge Elbir
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | - Özge Alp Topbaş
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | - Tuğba Kocabaş
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | - Ömer Aydemir
- Department of Psychiatry, Manisa Celal Bayar University School of Medicine, Manisa, Turkey
| | | | - Adem Aydın
- Department of Psychiatry, Necmettin Erbakan University School of Medicine, Konya, Turkey
| | - Abdullah Atli
- Department of Psychiatry, Dicle University School of Medicine, Diyarbakir, Turkey
| | - Abdullah Atli
- Department of Psychiatry, Dicle University School of Medicine, Diyarbakır, Turkey
| | - Pelin Avcu Çelik
- Department of Psychiatry, İskenderun State Hospital, Hatay, Turkey
| | | | - Deniz Argüz Çıldır
- Department of Child And Adolescent Psychiatry, Tepecik Training and Research Hospital, Izmir, Turkey
| | - Aylin Özbek
- Department of Child and Adolescent Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey
| | - Aybuke Tuğçe Mustan
- Department of Child And Adolescent Psychiatry, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
| | - Ayşe Sevgi Karadağ
- Department of Ophthalmology, Adiyaman University School of Medicine, Adiyaman, Turkey
| | - Aysun Kalenderoğlu
- Department of Psychiatry, Adiyaman University School of Medicine, Adiyaman, Turkey
| | - Mehmet Hamdi Örüm
- Department of Psychiatry, Adiyaman University School of Medicine, Adiyaman, Turkey
| | | | | | - Aysun Kalenderoğlu
- Department of Psychiatry, School of Medicine, Adiyaman University, Adiyaman, Turkey
| | - Ayşe Sevgi Karadağ
- Department of Ophthalmology, Adiyaman University School of Medicine, Adiyaman, Turkey
| | - Mehmet Hamdi Örüm
- Department of Psychiatry, School of Medicine, Adiyaman University, Adiyaman, Turkey
| | | | - Dilek Bingöl Aydın
- Department of Pediatrics, Sakarya University School of Medicine, Sakarya, Turkey
| | - Bahri Elmas
- Department of Pediatrics, Sakarya University School of Medicine, Sakarya, Turkey
| | - Serhat Nasıroğlu
- Department of Child and Adolescent Psychiatry, Sakarya University School of Medicine, Sakarya, Turkey
| | - Engin Aydın
- Department of Pediatrics, Sakarya University School of Medicine, Sakarya, Turkey
| | - Öner Özdemir
- Department of Pediatric Allergy and Immunology, Sakarya University School of Medicine, Sakarya, Turkey
| | - Özcan Erel
- Department of Biochemistry, Yıldırım Beyazıt University School of Medicine, Ankara, Turkey
| | - Hatice Altun
- Department of Child and Adolescent Psychiatry, Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey
| | - Ülker Fedai
- Department of Psychiatry, Balikligol State Hospital, Sanliurfa, Turkey
| | - Mehmet Asoğlu
- Department of Psychiatry, Harran University School of Medicine, Sanliurfa, Turkey
| | - Rümeysa Yeni Elbay
- Department of Psychiatry, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Hasan Turan Karatepe
- Department of Psychiatry, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Celal Ulaşoğlu
- Department of Gastroenterology, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
| | - Hamza Ayaydın
- Department of Child and Adolescent Psychiatry, Harran University School of Medicine, Sanliurfa, Turkey
| | - Fethiye Kılıçaslan
- Department of Child and Adolescent Psychiatry, Harran University School of Medicine, Sanliurfa, Turkey
| | - Mehmet Asoğlu
- Department of Psychiatry, Harran University School of Medicine, Sanliurfa, Turkey
| | - Berkan Şahin
- Iğdır State Hospital, Child and Adolescent Psychiatry, Iğdır, Turkey
| | - Koray Karabekiroğlu
- Ondokuz Mayıs University School of Medicine, Child and Adolescent Psychiatry, Samsun, Turkey
| | - Abdullah Bozkurt
- Konya Training And Research Hospital, Child and Adolescent Psychiatry, Konya, Turkey
| | - Miraç Barış Usta
- Samsun Training And Research Hospital, Child and Adolescent Psychiatry, Samsun, Turkey
| | - Muazzez Aydın
- Ondokuz Mayıs University School of Medicine, Child and Adolescent Psychiatry, Samsun, Turkey
| | - Cansu Çobanoğlu
- Ondokuz Mayıs University School of Medicine, Child and Adolescent Psychiatry, Samsun, Turkey
| | - Hüseyin Kara
- Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey
| | - Yalçın Kahya
- Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey
| | - Özgen Özçelik
- Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey
| | - Dilara İnan
- Akdeniz University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Antalya, Turkey
| | - Mehmet Murat Kuloğlu
- Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey
| | - Ali Ercan Altınöz
- Department of Psychiatry, Eskişehir Osmangazi University School of Medicine, Eskişehir, Turkey
| | - Ferdi Köşger
- Department of Psychiatry, Eskişehir Osmangazi University School of Medicine, Eskişehir, Turkey
| | - Altan Eşsizoğlu
- Department of Psychiatry, Eskişehir Osmangazi University School of Medicine, Eskişehir, Turkey
| | - Mehmet Arslan
- Department of Psychiatry, Babaeski State Hospital, Kırklareli, Turkey
| | | | - Duygu Göktaş
- Department of Psychiatry, Yozgat City Hospital, Yozgat, Turkey
| | - İkbal İnanlı
- Department of Psychiatry, Konya Training and Research Hospital, Konya, Turkey
| | - Saliha Çalışır
- Department of Psychiatry, Konya Training and Research Hospital, Konya, Turkey
| | - İbrahim Eren
- Department of Psychiatry, Konya Training and Research Hospital, Konya, Turkey
| | - Zeynep Baran Tatar
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Erhan Kurt
- Bakirkoy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
| | - Gokhan Unal
- Erciyes University School of Pharmacy, Department pf Pharmacology, Kayseri, Turkey
| | - Feyza Aricioglu
- Marmara University School of Pharmacy, Department of Pharmacology and Psychopharmacology Research Unit, Istanbul, Turkey
| | - Fatih Hilmi Cetin
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Hasan Ali Guler
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Mustafa Esad Tezcan
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | - Serhat Turkoglu
- Department of Child and Adolescent Psychiatry, Selçuk University School of Medicine, Konya, Turkey
| | | | | | | | - Çigdem Yektaş
- Duzce University School of Medicine, Department of Child and Adolescent Psychiatry, Duzce, Turkey
| | - Recep Eroz
- Duzce University School of Medicine, Department of Child and Adolescent Psychiatry, Duzce, Turkey
| | - Gokhan Yurdakul
- Ondokuz Mayıs University Health Sciences Institute, Samsun, Turkey
| | - Mahmut Cakır
- Child Psychiatry Clinic, SS Amasya Education and Research Hospital, Amasya, Turkey
| | | | - Saliha Baykal
- Namık Kemal University School of Medicine, Child and Adolescent Psychiatry Department, Tekirdag, Turkey
| | - Mirac Barıs Usta
- Child Psychiatry Clinic, Samsun Education and Research Hospital, Samsun, Turkey
| | | | - Koray Karabekiroglu
- Ondokuz Mayıs University School of Medicine, Department of Child Psychiatry, Samsun, Turkey
| | - Yasemin Yulaf
- Department of Psychology, Istanbul Gelisim University, Istanbul, Turkey
| | - Funda Gümştaş
- Child and Adolescent Psychiatry Clinic, Marmara University Education Research Hospital, Istanbul, Turkey
| | - Sebla Gökçe
- Child and Adolescent Psychiatry Clinic, Maltepe University School of Medicine, Istanbul, Turkey
| | - Yankı Yazgan
- Child and Adolescent Psychiatry Clinic, Marmara University School of Medicine, Istanbul, Turkey
| | - Çağdaş Öykü Memiş
- Departent of Psychiatry, School of Medicine, Adnan Menderes, Aydın, Turkey
| | - Doğa Sevincok
- Departmet of Child and Adolescent Psychiatry, Adnan Menderes University School of Medicine, Aydın, Turkey
| | - Bilge Doğan
- Departent of Psychiatry, School of Medicine, Adnan Menderes, Aydın, Turkey
| | - Ayşe Kutlu
- Departmet of Child and Adolescent Psychiatry, Behcet Uz Child Diseases and Neurosurgery Research and Training Hospital, İzmir, Turkey
| | - Burcu Çakaloz
- Departmet of Child and Adolescent Psychiatry, Pamukkale University School of Medicine, Denizli, Turkey
| | - Levent Sevinçok
- Departent of Psychiatry, School of Medicine, Adnan Menderes, Aydın, Turkey
| | - Deniz Argüz Çıldır
- Department of Child and Adolescent Psychiatry, Tepecik Research and Training Hospital, Izmir, Turkey
| | - Tugba Kalyoncu
- Department of Child and Adolescent Psychiatry, Tepecik Research and Training Hospital, Izmir, Turkey
| | - Fazilet Arkat Ergüvendi
- Department of Child and Adolescent Psychiatry, Tepecik Research and Training Hospital, Izmir, Turkey
| | - Çağatay Uğur
- Health Sciences University, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Child and Adolescent Psychiatry Department
| | - İbrahim Yağcı
- Kars Harakani State Hospital, Department of Psychiatry, Kars, Turkey
| | - Sema Avcı
- Kars Harakani State Hospital, Department of Emergency, Kars, Turkey
| | - Yüksel Kıvrak
- Kafkas University School of Medicine, Department of Psychiatry, Kars, Turkey
| | - Alişan Burak Yaşar
- Department of Psychiatry, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Ceyhun Sayman
- Department of Neurology, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Serap Erdoğan Taycan
- Department of Psychiatry, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Yılmaz Çetinkaya
- Department of Neurology, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Anıl Gündüz
- Department of Psychiatry, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Hülya Tireli
- Department of Neurology, Health Sciences University Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
| | - Kemal Utku Yazici
- Firat University School of Medicine, Department of Child and Adolescent Psychiatry, Elazig, Turkey
| | - Ipek Percinel Yazici
- Firat University School of Medicine, Department of Child and Adolescent Psychiatry, Elazig, Turkey
| | - Yüksel Kıvrak
- Kafkas University School of Medicine, Department Psychiatry, Kars, Turkey
| | | | - Süleyman Gül
- Kafkas University School of Science, Department of Molecular Biology, Kars, Turkey
| | - İbrahim Yağcı
- Kars Harakani State Hospital, Department of Psychiatry, Kars, Turkey
| | - Ipek Percınel Yazici
- Firat University School of Medicine, Department of Child and Adolescent Psychiatry, Elazig, Turkey
| | - Kemal Utku Yazici
- Firat University School of Medicine, Department of Child and Adolescent Psychiatry, Elazig, Turkey
| | - Deniz Argüz Çıldır
- Department of Child And Adolescent Psychiatry, Tepecik Research and Training Hospital, Izmir, Turkey
| | - Aylin Özbek
- Department of Child and Adolescent Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey
| | - Ayçin Darıcı Sümer
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Esra Çöp
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Duygu Bilgili
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Müge Şahin
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Gülser Şenses Dinç
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Özlem Hekim
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Emine Dibek Mısırlıoğlu
- Department of Pediatrics, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Funda Kurt
- Department of Pediatrics, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Zeynep Göker
- Department of Child and Adolescent Psychiatry, Ankara Pediatric Hematology Oncology Training and Research Hospital, Ankara, Turkey
| | - Özden Üneri
- Department of Child and Adolescent Psychiatry, Ankara Yıldırım Beyazıt University, Ankara, Turkey
| | - Yüksel Kıvrak
- Kafkas University School of Medicine, Department Psychiatry, Kars, Turkey
| | - Yüksel Kıvrak
- Kafkas University School of Medicine, Department Psychiatry, Kars, Turkey
| | - İbrahim Yağcı
- Kars Harakani State Hospital, Department of Psychiatry, Kars, Turkey
| | - Yüksel Kıvrak
- Kafkas University School of Medicine, Department Psychiatry, Kars, Turkey
| | - Eray Atalay
- Kafkas University School of Medicine, Department Internal Medicine, Kars, Turkey
| | - İrem Yıldırım
- Kafkas University School of Medicine, Department of Neurology, Kars, Turkey
| | - İbrahim Yağcı
- Kars Harakani State Hospital, Department of Psychiatry, Kars, Turkey
| | - Ali İnaltekin
- Kafkas University School of Medicine, Department Psychiatry, Kars, Turkey
| | - Bengü Yücens
- Afyon Kocatepe University Medical Faculty, Department of Psychiatry, Afyonkarahisar, Turkey
| | - Vahap Ozan Kotan
- Başkent University School of Medicine, Department of Psychiatry, Ankara, Turkey
| | - Nihal Özkayar
- Hitit University School of Medicine, Department of Nephrology, Çorum, Turkey
| | - Fatih Dede
- Ankara Numune Research and Training Hospital, Department of Nephrology, Ankara, Turkey
| | - Rabia Nazik Yüksel
- Ankara Numune Research and Training Hospital, Department of Psychiatry, Ankara, Turkey
| | - Şenol Bayram
- Ankara Numune Research and Training Hospital, Department of Psychiatry, Ankara, Turkey
| | - Zeynep Kotan
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Psychiatry, Ankara, Turkey
| | - Erol Göka
- Ankara Numune Research and Training Hospital, Department of Psychiatry, Ankara, Turkey
| | | | - Gökçe Nur Say
- Ondokuz Mayis University School of Medicine, Department Psychiatry, Samsun, Turkey
| | | | | | - Merve Kalyoncu
- Ondokuz Mayis University School of Medicine, Department Psychiatry, Samsun, Turkey
| | - Muazzez Aydın
- Ondokuz Mayis University School of Medicine, Department Psychiatry, Samsun, Turkey
| | - Cansu Çobanoğlu
- Ondokuz Mayis University School of Medicine, Department Psychiatry, Samsun, Turkey
| | - Özlem Beğinoğlu
- Harran University School of Medicine, Department of Psychiatry
| | - Mehmet Asoğlu
- Harran University School of Medicine, Department of Psychiatry
| | - Bahadir Bilgin Basgoz
- Health Sciences University Gulhane School of Medicine, Department of Internal Medicine, Ankara, Turkey
| | - Semra Ince
- Health Sciences University Gulhane School of Medicine, Department of Nuclear Medicine, Ankara, Turkey
| | - Umut Safer
- Health Sciences University Gulhane School of Medicine, Department of Internal Medicine, Ankara, Turkey
| | - İlker Tasci
- Health Sciences University Gulhane School of Medicine, Department of Internal Medicine, Ankara, Turkey
| |
Collapse
|
29
|
Dede F, Yazici Ozgur C. Aging and the Kidneys. Istanbul Med J 2017. [DOI: 10.5152/imj.2017.26928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
30
|
Bayrakci N, Tasoglu O, Ozkayar N, Ada B, Turhan T, Ates I, Dede F. MP407THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY STATUS AND SERUM IRISIN AND MYOSTATIN LEVELS İN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx170.mp407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
31
|
Ates I, Bulut M, Ozkayar N, Dede F. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med 2016; 35:630-4. [PMID: 26354352 PMCID: PMC4579108 DOI: 10.3343/alm.2015.35.6.630] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Revised: 05/13/2015] [Accepted: 08/03/2015] [Indexed: 11/19/2022] Open
Abstract
Background We aimed to determine the association between platelet indices including plateletcrit (PCT), mean platelet volume (MPV), platelet distribution width (PDW), and proteinuria associated with hypertension (HT) as well as the relative power of each to predict proteinuria. Methods The study included 223 patients (68 men and 155 women) with primary HT. PCT, MPV, PDW, and proteinuria levels were measured. The patients were divided into two groups according to proteinuria status based on 24-hr urinary protein excretion: proteinuria (+) group (15 men and 40 women) and proteinuria (-) group (53 men and 115 women). Results The mean and SD of platelet count, PDW, PCT, and MPV were 278.8±49.6×109/L, 13.5±1.8%, 0.31±0.07%, and 11.3±2.6 fL, respectively. The mean platelet count, PCT, MPV, and PDW were significantly higher in the proteinuria (+) group than in the proteinuria (-) group (P<0.05); there were no significant differences in the other blood parameters between the two groups. The platelet count, PCT, MPV, and PDW were independent risk factors predictive of proteinuria according to a stepwise regression analysis of PDW, PCT, and MPV. PCT was the strongest independent predictor of proteinuria. Conclusions The platelet indices PCT, PDW, and MPV were significantly higher in patients with proteinuria than in those without it. Among these three indices, PCT was the strongest predictor of proteinuria.
Collapse
Affiliation(s)
- Ihsan Ates
- Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey
| | - Mesudiye Bulut
- Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey
| | - Nihal Ozkayar
- Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey.
| | - Fatih Dede
- Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey
| |
Collapse
|
32
|
Yenigun EC, Aypak C, Turgut D, Aydin MZ, Dede F. MP325EFFECT OF METABOLI˙C ASCIDOSIS ON QT INTERVALS IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw189.25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Ates I, Özkayar N, Toprak G, Yılmaz N, Dede F. Factors associated with mortality in patients presenting to the emergency department with severe hypernatremia. Intern Emerg Med 2016; 11:451-9. [PMID: 26688326 DOI: 10.1007/s11739-015-1368-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2015] [Accepted: 11/30/2015] [Indexed: 10/22/2022]
Abstract
Hypernatremia is a common electrolyte disorder associated with prolonged hospitalization and death. Severe hypernatremia is defined as a serum sodium (Na(+)) concentration >160 mmol/L. To the best of our knowledge, there is little information on patients with severe hypernatremia, Na(+) >160 mmol/L. Therefore, in this study, we aimed to determine the frequency, demographic and clinical characteristics, comorbid conditions and treatment strategies in patients presenting to the emergency department with severe hypernatremia, and also to evaluate the effects of these factors on mortality. A retrospective chart review was performed on patients presenting to the emergency department between January 2011 and June 2014. Patients with Na(+) >160 mmol/L were screened retrospectively via the hospital electronic information management system and patient medical record files. During the 3.5 years of screening, 256 patients (0.04 %) with Na(+) >160 mmol/L presented to the emergency department. The mean age of the patients included in the study was 74.4 ± 15.2 years, mean Na(+) level was 168.7 ± 7.4 mmol/L and, mean mortality was 49.5 % during the hospitalization. Multivariable Cox regression analysis showed that low systolic blood pressure, low pH, Na(+) >166 mmol/L, increased plasma osmolarity, mean sodium reduction rate ≤-0.134 mmol/L/h, dehydration, and, pneumonia to be independently associated with mortality. This study describes the demographic and clinical characteristics of patients with Na(+) >160 mmol/L in a large population along with comorbid conditions, incidence, treatment strategies and, its association with mortality.
Collapse
Affiliation(s)
- Ihsan Ates
- Department of Internal Medicine, Ankara Numune Training and Research Hospital, Sıhhıye, 06100, Ankara, Turkey.
| | - Nihal Özkayar
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Güvenç Toprak
- Department of Internal Medicine, Ankara Numune Training and Research Hospital, Sıhhıye, 06100, Ankara, Turkey
| | - Nisbet Yılmaz
- Department of Internal Medicine, Ankara Numune Training and Research Hospital, Sıhhıye, 06100, Ankara, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
34
|
Inan B, Ates I, Ozkayar N, Kundi H, Topcuoglu C, Dede F, Sennaroglu E. Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension? Clin Exp Hypertens 2016; 38:294-8. [PMID: 27018581 DOI: 10.3109/10641963.2015.1089883] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE In this study, our aim was to determine total oxidative stress and asymmetric dimethylarginine (ADMA) levels in patients with masked hypertension (MHT) and to examine their association with blood pressure. METHODS Fifty patients diagnosed with MHT and 48 healthy volunteers without any known chronic diseases have been included in this study. RESULTS When compared to the control group, patients with MHT had higher levels of mean ADMA (p < 0.001), total oxidant status (TOS) (p < 0.001), and oxidative stress index (OSI) (p < 0.001), and a lower mean total antioxidant status (TAS) (p < 0.001) level. While a positive correlation was determined between the systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels with ADMA, TOS, and OSI levels, a negative correlation was determined with the TAS level. During the stepwise multivariable logistic regression analysis, age (OR = 1.221; p = 0.003), body mass index (OR = 1.512; p = 0.005), low density lipoprotein (OR = 0.925; p = 0.016), ADMA (OR = 1.200; p = 0.002), and OSI (OR = 3.750; p = 0.002) levels were determined to be the predictors of MHT. During the linear regression analysis, it was determined that the independent risk factors of SBP and DBP are ADMA and OSI, and the independent risk factor of TOS, OSI, and ADMA is SBP. Our study found out that oxidative stress and ADMA levels of patients with MHT are higher than those of the control group. ADMA and OSI were determined to be predictors of MHT. CONCLUSION Based on these results, it could be said that oxidative stress, and therefore the ADMA level, could have an effect on the etiopathogenesis of MHT.
Collapse
Affiliation(s)
- Bayram Inan
- a Internal Medicine Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Ihsan Ates
- a Internal Medicine Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Nihal Ozkayar
- b Nephrology Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Harun Kundi
- c Cardiology Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Canan Topcuoglu
- d Biochemistry Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Fatih Dede
- b Nephrology Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| | - Engin Sennaroglu
- a Internal Medicine Department , Ankara Numune Training and Research Hospital , Ankara , Turkey
| |
Collapse
|
35
|
Yenigun EC, Bayrakci N, Cevher SK, Ozkayar N, Dede F. Systemic Lupus Erythematosus as a Rare Cause of Anemia Resistant to Erythropoiesis-stimulating Agents. Iran J Kidney Dis 2016; 10:97-99. [PMID: 26921753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 06/05/2015] [Accepted: 09/09/2015] [Indexed: 06/05/2023]
Abstract
Erythropoiesis-stimulating agents (ESAs) play an important role in the management of anemia in patients with chronic kidney disease, but the goals cannot be reached in 5% to 10% of the patients despite high-dose ESA treatment. In case of ESA resistance, all causes of anemia encountered in the general population should be carefully reviewed. We present a patient examined for ESA resistance that was diagnosed with systemic lupus erythematosus and subsequently showed improvement of anemia with systemic corticosteroids.
Collapse
Affiliation(s)
- Ezgi Coskun Yenigun
- Department of Nephrology, Ankara Numune Research and Education Hospital, Ankara, Turkey.
| | | | | | | | | |
Collapse
|
36
|
Gungor S, Asa S, Özgür A, Aras M, Dede F. Infected concha bullosa mimicking a malignant lesion on (18)F-FDG PET/CT. Rev Esp Med Nucl Imagen Mol 2016; 35:270-1. [PMID: 26833383 DOI: 10.1016/j.remn.2015.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 11/28/2015] [Accepted: 12/03/2015] [Indexed: 11/15/2022]
Affiliation(s)
- S Gungor
- Department of Nuclear Medicine, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.
| | - S Asa
- Department of Nuclear Medicine, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey
| | - A Özgür
- Department of Otorhinolaryngology, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey
| | - M Aras
- Department of Nuclear Medicine, Bulent Ecevit University School of Medicine, Zonguldak, Turkey
| | - F Dede
- Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey
| |
Collapse
|
37
|
Bayrakci N, Ozkayar N, Ersozen ME, Colak A, Oguz EG, Dede F. Coexistence of immunoglobulin M nephropathy and autoimmune hemolytic anemia: 2 rare entities. Iran J Kidney Dis 2015; 9:472-474. [PMID: 26552355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 08/17/2015] [Indexed: 06/05/2023]
Abstract
Immunoglobulin M (IgM) nephropathy is described as mesengial proliferative glomerulonephritis with diffuse mesengial IgM deposition. We report a patient diagnosed with IgM nephropathy and concomitant autoimmune hemolytic anemia syndrome associated with cold-reacting autoantibodies. Complete remission was achieved with systemic corticosteroid and plasmapheresesis.
Collapse
Affiliation(s)
- Nergiz Bayrakci
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey.
| | | | | | | | | | | |
Collapse
|
38
|
Koksal Cevher S, Coskun Yenigun E, Ozkayar N, Bayrakci N, Dede F. Diabetic Ketoacidosis associated with Steroid in a Renal Transplant Recipient. Istanbul Med J 2015. [DOI: 10.5152/imj.2015.58076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
39
|
Ateş İ, Ozkayar N, Altay M, Yilmaz FM, Topçuoğlu C, Alışık M, Erel Ö, Dede F. Is disulphide/thiol ratio related to blood pressure in masked hypertension? Clin Exp Hypertens 2015; 38:150-4. [PMID: 26418425 DOI: 10.3109/10641963.2015.1060995] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Dynamic thiol/disulphide homeostasis plays a critical role in numerous intracellular enzymatic pathways including antioxidant defence and detoxification. In this study, we sought to investigate dynamic thiol/disulphide homeostasis in patients with masked hypertension (MHT) and its relationship with blood pressure. Forty patients (23 men, 17 women) with newly diagnosed MHT and not yet on medical therapy, and 40 healthy volunteers (21 men, 19 women) were enrolled. Blood thiol/disulphide homeostasis was measured in both groups. Serum native and total thiol levels were measured using the novel, fully automated colorimetric method developed by Erel et al. Serum disulphide level was calculated as (serum total thiol - serum native thiol)/2. Native and total thiol levels (p = 0.001) and native thiol/total thiol ratio (p = 0.023) were found to be lower in patients with MHT when compared to those of the control group. Disulphide level and ratios of disulphide/native thiol and disulphide/total thiol were higher in patients with MHT than in the control group (p = 0.001). A positive correlation of systolic blood pressure (SBP) and diastolic blood pressure (DBP) was observed with disulphide/native thiol ratio (p < 0.001). Stepwise multivariable regression analysis showed disulphide/native thiol ratio to be an independent risk factor of SBP and DBP, and SBP to be an independent risk factor of disulphide/thiol ratio (p = 0.001). In this study, we found that dynamic thiol/disulphide homeostasis shifted towards disulphide formation due to thiol oxidation in patients with MHT. Prospective randomised controlled studies are required to elucidate whether abnormal thiol/disulphide status lies in the pathogenesis of MHT or is a consequence of MHT.
Collapse
Affiliation(s)
| | | | | | - Fatma Meriç Yilmaz
- c Biochemistry Department , Ankara Numune Education and Research Hospital , Ankara , Turkey , and.,d Department of Biochemistry , Medical Faculty, Yildirim Beyazit University , Ankara , Turkey
| | - Canan Topçuoğlu
- c Biochemistry Department , Ankara Numune Education and Research Hospital , Ankara , Turkey , and
| | - Murat Alışık
- d Department of Biochemistry , Medical Faculty, Yildirim Beyazit University , Ankara , Turkey
| | - Özcan Erel
- d Department of Biochemistry , Medical Faculty, Yildirim Beyazit University , Ankara , Turkey
| | | |
Collapse
|
40
|
Dede F, Ayli D, Gonul I, Yuksel O, Ozturk R, Yildiz A, Yenigun E, Piskinpasa S, Turgut D, Koc E, Odabas AR. The effect of Helicobacter pylori eradication on proteinuria in patients with primary glomerulonephritis. Arch Med Sci 2015; 11:764-9. [PMID: 26322088 PMCID: PMC4548018 DOI: 10.5114/aoms.2013.37013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2011] [Revised: 09/07/2011] [Accepted: 10/19/2011] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION Glomerulonephritis is still the primary cause among the diseases causing end stage renal disease. Helicobacter pylori (HP), also having a local proinflammatory effect on gastric mucosa, can trigger a local and systemic inflammatory response, and consequently have a role in the development of extragastrointestinal defects. MATERIAL AND METHODS The study was composed of patients diagnosed with primary glomerulonephritis who had dyspeptic complaints throughout the diagnosis. Patients who received endoscopic biopsy upon the determination of pathologic findings in their upper gastrointestinal endoscopy were HP positive in their biopsy material. A triple eradication therapy was initiated for HP. RESULTS The study included 14 female and 19 male patients, 33 in total, whose biopsy material was determined to be HP positive. Before the eradication for HP, we found serum albumin to be 34.0 (19.0-51.0) g/l, serum total protein 58.6 ±12.9 g/l, serum creatinine 0.9 (0.5-1.2) and proteinuria 3069 (652-12392) mg/day in 24-hour urine. After the eradication, however, serum albumin was found to be 40 (20-52) g/l, serum total protein 62.3 ±11.1 g/l, serum creatinine 1.02 (0.6-1.29) mg/dl and proteinuria was 2850 (172-15181) mg/day in 24-hour urine. A comparison of the results showed that a statistically significant difference is established between the serum albumin, total protein and creatinine values (p = 0.001, p = 0.001 and p = 0.021, respectively), but not between proteinuria values in 24-hour urine (p = 0.990). CONCLUSIONS Patients with primary glomerulonephritis, HP eradication treatment has an effect on serum albumin levels.
Collapse
Affiliation(s)
- Fatih Dede
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Deniz Ayli
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ipek Gonul
- Department of Pathology, Gazi University, Faculty of Medicine, Ankara, Turkey
| | - Osman Yuksel
- Department of Gastroenterology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ramazan Ozturk
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ayla Yildiz
- Department of Gastroenterology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ezgi Yenigun
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Serhan Piskinpasa
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Didem Turgut
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Eyup Koc
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| | - Ali Riza Odabas
- Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
41
|
Piskinpasa S, Agbaht K, Akoglu H, Akyel F, Ozkayar N, Yenigun Coskun E, Turgut D, Koc E, Odabas AR, Dede F. Unknown aspect of the old disease: does dyslipidemia in systemic AA amyloidosis differ from the dyslipidemia in primary glomerulonephritis? Ren Fail 2015; 37:1273-9. [PMID: 26181645 DOI: 10.3109/0886022x.2015.1065427] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
AIM To investigate the nature of dyslipidemia and its diversity in patients with systemic AA amyloidosis. METHODS The reports of the kidney biopsies performed due to nephrotic proteinuria (>3.5 g/day/1.73 m(2)) with preserved renal function [glomerular filtration rate (GFR) >60 mL/min/1.73 m(2)] were reviewed. Clinical and laboratory data of the patients with systemic AA amyloidosis and primary glomerulonephritis (PG) were analyzed. RESULTS A total of 104 (systemic AA amyloidosis: 43, PG: 61) patients were included in the study. Proteinuria and GFR levels were similar in both the groups. Patients with systemic AA amyloidosis group had lower serum albumin (p = 0.002), lower hemoglobin levels (p = 0.001), higher platelet counts (p = 0.002) and higher C-reactive protein levels (p = 0.001) compared to patients in PG group. Although the frequency of dyslipidemia was similar in the groups (86.0 vs. 93.4%), patients with systemic amyloidosis had both lower values of LDL-C (4.56 ± 2.05 vs. 5.49 ± 2.23 mmol/L, p = 0.028) and HDL-C (1.19 ± 0.36 vs. 1.35 ± 0.39 mmol/L, p = 0.035). Serum lipid levels were correlated with serum total protein, albumin and proteinuria levels in PG group. However, in the systemic amyloidosis group, only one clear correlation between serum lipid and hemoglobin levels was estimated. A multivariate analysis demonstrated that LDL-C was independently associated with the etiology of nephrotic proteinuria, serum total protein, serum albumin (inversely) and hemoglobin levels. CONCLUSIONS Although dyslipidemia is closely associated with serum total protein, albumin and proteinuria in patients with PG, there is no clear such association in patients with systemic amyloidosis. Correlation between serum lipid and hemoglobin levels in this group and other findings point out that probably complex mechanisms take place in dyslipidemia of nephrotic syndrome caused by systemic AA amyloidosis.
Collapse
Affiliation(s)
- Serhan Piskinpasa
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Kemal Agbaht
- b Department of Endocrinology and Metabolic Diseases , Balikesir State Hospital , Balikesir , Turkey
| | - Hadim Akoglu
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Fatma Akyel
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Nihal Ozkayar
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Ezgi Yenigun Coskun
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Didem Turgut
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Eyup Koc
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Ali Riza Odabas
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| | - Fatih Dede
- a Department of Nephrology , Ankara Numune Educational and Research Hospital , Ankara , Turkey and
| |
Collapse
|
42
|
Ates I, Ozkayar N, Topcuoglu C, Dede F. Relationship between oxidative stress parameters and asymptomatic organ damage in hypertensive patients without diabetes mellitus. SCAND CARDIOVASC J 2015; 49:249-56. [DOI: 10.3109/14017431.2015.1060355] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- Ihsan Ates
- Department of Internal Medicine, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Nihal Ozkayar
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Canan Topcuoglu
- Department of Biochemistry, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Fatih Dede
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
43
|
Gungor S, Aras M, Novruzov F, Sunbul M, Dede F. Incidentally detected right-to-left intracardiac shunt with Eisenmenger syndrome on V/Q SPECT/CT. Rev Esp Med Nucl Imagen Mol 2015. [DOI: 10.1016/j.remnie.2015.03.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Gungor S, Aras M, Novruzov F, Sunbul M, Dede F. Incidentally detected right-to-left intracardiac shunt with Eisenmenger syndrome on V/Q SPECT/CT. Rev Esp Med Nucl Imagen Mol 2015; 34:215-6. [DOI: 10.1016/j.remn.2014.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2014] [Revised: 09/25/2014] [Accepted: 09/26/2014] [Indexed: 10/24/2022]
|
45
|
Yenigun EC, Dede F, Ozturk R, Turgut D, Koc E, Piskinpasa SV, Ozkayar N, Odabas AR. Non-Diabetic renal disease in Diabetes Mellitus: clinical features and renal biopsy findings. Hippokratia 2015; 19:148-152. [PMID: 27418764 PMCID: PMC4938106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
AIM Renal diseases in diabetes mellitus (DM) patients, include diabetic nephropathies (DN) and non-diabetic renal diseases (NDRD). The clinical differentiation among them is usually not so clear and effective. Aim of this study which examined renal biopsies in patients with type-2 DM was to identify the prevalence and the nature of NDRD. MATERIALS AND METHODS We recorded the clinical and laboratory finding alongside with the histopathological examination of the renal biopsies obtained from 71 type-2 DM patients who underwent renal biopsy in our center. Based on the renal biopsy findings patients were classified into two groups (DN and NDRD) and data was compared between the two groups. RESULTS There were 42 women and 29 men; aged 55 ± 12 years. In patients with DN (n: 34), diabetic retinopathy was more common [16 (47.1 %) vs. 6 (16.2 %) respectively, p =0.01], duration of DM was longer (108.8 ± 58.8 months vs 57.8 ± 55.9 months respectively, p <0.001) and the degree of proteinuria was more severe (6 ± 4.3 g/day vs. 4.5 ± 4.6 g/day respectively, p =0.04) compared to the patients with NDRD. Regression analysis revealed that diabetes duration >60 months, presence of diabetic retinopathy and proteinuria >3.5 g/day were independent predictors of DN with 79.4 % sensitivity and 86.5% specificity. Focal segmental glomerulosclerosis was the most frequent diagnosis in patients with NDRD. CONCLUSIONS The prevalence of NDRD is remarkably frequent in DM patients in whom nephrologists consider renal biopsy an appropriate measure. Short duration of DM, degree of proteinuria and absence of retinopathy were predictors of NDRD. Hippokratia 2015; 19 (2):148-152.
Collapse
Affiliation(s)
- E C Yenigun
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - F Dede
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - R Ozturk
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - D Turgut
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - E Koc
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - S V Piskinpasa
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - N Ozkayar
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| | - A R Odabas
- Nephrology Department of Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
46
|
Bayrakci N, Ozkayar N, Akyel F, Ates I, Akyel S, Dede F. The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients. Hippokratia 2015; 19:114-118. [PMID: 27418758 PMCID: PMC4938100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGROUND Non-dipper hypertensive patients have a higher risk of cardiovascular disease (CVD) than dipper hypertensive patients. Inflammation plays an important role in the pathogenesis and progression of CVD. This study aimed to determine the relationship between the platelet-to-lymphocyte ratio (PLR), and dipper and non-dipper hypertension. MATERIALS AND METHODS This prospective study included 199 consecutive patients that were diagnosed with primary hypertension. According to ambulatory blood pressure monitoring measurements, non-dipper and dipper group were determined. PLR was determined based on the platelet count and lymphocyte count in the complete blood count. RESULTS The non-dipper group included 103 patients (74 females and 29 males; mean age: 52.37 ± 10.7 years) and the dipper group included 96 patients (65 females and 31 males; mean age: 48.40 ± 11.1 years). Mean systolic blood pressure was significantly higher in the non-dipper group than in the dipper group (124 ± 15.1 mmHg versus 120 ± 11.2 mmHg, p =0.032) and the median PLR was significantly higher in the non-dipper group than in the dipper group [132.15 (range: 69.64-400) versus 117.0 (range: 53.52-192.26), p = 0.001], whereas the mean white blood cell count (6.86 ± 1.43 × 10³/ μL versus 7.24 ± 1.26 × 10³/μL, p =0.046) and median lymphocyte count [2.09 (range: 0.95-3.92) × 10³/μL versus 2.24 (range: 0.97-3.98) × 10³/μL, p =0.001) were significantly lower in the non-dipper group. CONCLUSION Median PLR was significantly higher in the non-dipper hypertensive patients than in the dipper hypertensive patients. We think this finding further supports the role of an increase in inflammatory response in non-dipper hypertension. Hippokratia 2015; 19 (2):114-118.
Collapse
Affiliation(s)
- N Bayrakci
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - N Ozkayar
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - F Akyel
- Department of Internal Medicine, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - I Ates
- Department of Internal Medicine, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - S Akyel
- Department of Cardiology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - F Dede
- Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
47
|
Ozkayar N, Akyel S, Dede F, Akyel F, Turgut D, Bulut M, Odabaş AR. Evaluation of heart rate recovery in patients with primary nephrotic syndrome. Hippokratia 2015; 19:109-113. [PMID: 27418757 PMCID: PMC4938099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGROUND/AIM Abnormal heart rate recovery after an exercise stress test is a strong predictor of cardiovascular death in healthy subjects and various patient groups. The aim of the present study was to investigate heart rate recovery (HRR), a cardiovascular risk factor, in patients with primary nephrotic syndrome (NS). MATERIAL AND METHODS Forty patients with primary NS (mean age 39.6 ± 9.3 years) and 42 healthy subjects (mean age 36.0 ± 7.9) were included in the study. HRR was calculated by subtracting the heart rates in the first, second, and third minutes of the recovery period from the maximum heart rate, reached during the exercise stress test. RESULTS The HRR in the first minute was significantly slower in the NS group compared with the control group (25.5 ± 10.1 and 32.4 ± 11.1, respectively; p =0.004). The HRR in the second and third minutes was also slower in the NS group, but the difference was not statistically significant. When a comparative analysis of HRR and the etiology of NS was carried out, no difference was found at any time point. CONCLUSIONS Impaired first minute HRR was identified in patients with NS. This suggests that primary NS patients should be monitored due to the potential increased risk of cardiovascular disease. Hippokratia 2015; 19 (2):109-113.
Collapse
Affiliation(s)
- N Ozkayar
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - S Akyel
- Cardiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - F Dede
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - F Akyel
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - D Turgut
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - M Bulut
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - A R Odabaş
- Nephrology Department, Istanbul Medeniyet University Medical Faculty, Istanbul, Turkey
| |
Collapse
|
48
|
Ozturk R, Yenigun EC, Dede F, Koc E, Turgut D, Piskinpasa SV, Ozkayar N, Odabas AR. Prognostic factors in crescentic glomerulonephritis: a single-center experience. Iran J Kidney Dis 2015; 9:31-38. [PMID: 25599734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/02/2013] [Accepted: 05/24/2014] [Indexed: 06/04/2023]
Abstract
INTRODUCTION Crescentic glomerulonephritis (CGN) is a fatal disease, rapidly leading to end-stage renal disease. Diagnosis should be accurate and treatment should be started immediately. We investigated the factors associated with the renal prognosis in CGN patients. MATERIALS AND METHODS Forty-one patients with CGN who were followed up at the Nephrology Clinic of Ankara Numune Education and Research Hospital were divided into 2 arms of the dialysis-dependent group after treatment and the group that was followed up without dialysis. Demographic and clinical features along with biopsy findings during time of diagnosis were evaluated for both groups. RESULTS The mean age was 41.3 ± 17.2 years old and 26 were men. Twenty patients developed end-stage renal disease, requiring long-term dialysis. The dialysis-dependent group had higher serum creatinine levels (8.2 ± 3.6 mg/dL versus 2.6 ± 2.5 mg/dL) and percentages of glomeruli with crescent (83.1 ± 19.1% versus 56.4 ± 11.9%), were more likely to have oligoruia-anuria (90.5% versus 9.5%) and be dialysis-dependent at admission (86.4% versus 13.6%), and had longer elapsed time until the beginning of treatment (18.9 ± 10.4 days versus 10.6 ± 3.0 days) after treatment. At admission, their serum creatinine was greater than 4.2 mg/dL and the rate of crescentic glomeruli was greater than 63%. CONCLUSIONS In patients with CGN, renal prognosis is poor and the time of admission to the hospital, degree of renal insufficiency, presence of oligo-anuria, dialysis requirement, and the percentage of crescentic glomeruli on biopsy are closely related to progression to end-stage renal disease.
Collapse
Affiliation(s)
| | - Ezgi Coskun Yenigun
- Ankara Numune Education and Research Hospital, Department of Nephrology, Ankara, Turkey.
| | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
Icodextrin may be used as an alternative to glucose as the osmotic agent in peritoneal dialysis with ultrafiltration failure. In general, icodextrin is known to be safe and well tolerated, but it can also cause hypersensitivity reactions such as skin rashes. Allergic rashes are generally defined as erythematous, itchy and maculopapular, visible over the trunk and the extremities. When a rash occurs, it generally develops early in therapy, is self-limited, and resolves without sequelae after the discontinuation of icodextrin. Although the safety and efficacy of icodextrin peritoneal dialysis solution is well documented, clinicians should be aware of the possibility of severe adverse cutaneous reactions to it. We report the case of a 23-year-old female who developed a skin rash following the use of icodextrin.
Collapse
Affiliation(s)
- Şimal Köksal Cevher
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Nihal Ozkayar
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - Fatih Dede
- Nephrology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
50
|
Ates I, Ozkayar N, Akyel F, Topcuoglu C, Akyel S, Barça AN, Dede F. The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients. BMC Nephrol 2014; 15:159. [PMID: 25273526 PMCID: PMC4190353 DOI: 10.1186/1471-2369-15-159] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Accepted: 09/29/2014] [Indexed: 01/08/2023] Open
Abstract
Background This study aimed to measure the serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and interleukin-17A (IL-17A) levels in hypertensive patients with/without asymptomatic organ damage (AOD), as well as to determine the relationship between the serum sTWEAK and IL17-A levels, and carotid intima media thickness (CIMT), proteinuria, retinopathy, and the left ventricle mass index (LVMI). Methods The study included 159 patients diagnosed with and followed-up for primary hypertension (HT); 79 of the patients had AOD (61 female and 18 male) and 80 did not (52 female and 28 male). sTWEAK and IL-17A levels were measured in all patients. Results The sTWEAK level was significantly lower in the patients with AOD than in those without AOD (858.4 pg/mL vs. 1151.58 pg/mL, P = 0.001). The sTWEAK level was negatively correlated with the mean microalbuminuria level and LVMI. The median IL-17A level was significantly higher in the patients with AOD than in those without AOD (2.34 pg/mL vs. 1.80 pg/mL, P = 0.001). There was a positive correlation between mean IL-17A level, and mean microalbuminuria level, CIMT, and LVMI. Multivariate logistic regression analysis showed that patient age, sTWEAK level, and mean 24-h systolic blood pressure were predictors of AOD. Conclusions The sTWEAK level was lower and IL-17A level was higher in the patients with AOD. It remains unknown if sTWEAK and IL-17A play a role in the pathophysiology of AOD. Prospective observational studies are needed to determine the precise role of sTWEAK and IL-17A in the development of target organ damage.
Collapse
Affiliation(s)
- Ihsan Ates
- Department of Nephrology, Ankara Numune Education and Research Hospital, Sıhhiye, Ankara 061100, Turkey.
| | | | | | | | | | | | | |
Collapse
|